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1. Summary 
1.1. English 
Cells encounter a plethora of DNA insults every day. To counteract these 
detrimental effects on the genome, they have evolved sophisticated 
mechanisms; on the one hand the cells detect the damage by specific DNA 
damage sensor proteins, which activate checkpoint proteins to either halt the 
cell cycle to allow repair, or, in cases of too massive DNA damage, guide the 
cell into controlled cell death, called apoptosis. Various DNA repair pathways 
on the other hand attempt to repair the damage, in the best case restoring the 
unaltered DNA, therefore preventing genome instability. The aim of this thesis 
was to investigate different DNA repair mechanisms in two different 
organisms, first in the radioresistant bacterium Deinococcus radiodurans (D. 
radiodurans) and second in human cells. In the first part, two putative DNA 
ligases of D. radiodurans were investigated, leading to the biochemical 
characterization of the NAD+-dependent DNA ligase of D. radiodurans. The 
DNA ligase activity was most efficient in the presence of 1mM MnCl2 whereas 
the substitution of MnCl2 by MgCl2 or CaCl2 reduced the activity about ten 
fold. A second, putative ATP-dependent DNA ligase showed no apparent 
ligase activity, although an adenylyltransferase intermediate could be 
identified. Furthermore, the characterization of the putative O6-
methylguanine-DNA methyltransferase (MGMT) of D. radiodurans was 
performed. Although cloning and purification were successful, the enzymatic 
characterization was not possible because no methyltransferase activity was 
observed, although folding of the protein was correct as it bound to DNA.  
In the second part, the in our laboratory discovered interaction of the human 
Rad9/Rad1/Hus1-complex (9-1-1 complex) with the apurinic/apyriminidinic 
endonuclease 1 (Ape1) was further characterized. With the use of protein 
fragments it was found that the endonuclease activity of Ape1 is located in its 
N-terminus. Furthermore the results indicated that the interaction of the 9-1-1 
complex with Ape1 involves the entire Ape1 protein. In addition, observation 
was made indicating a previously unknown interaction of the 9-1-1 complex 
with human DNA polymerase !. 
3
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1.2. German 
Zellen erfahren jeden Tag viele DNA Schäden. Um diesen nachteiligen 
Effekten auf das Genom entgegenzuwirken, haben die Zellen hochstehende 
Mechanismen entwickelt; auf der einen Seite detektieren sie die Schäden 
durch spezifische DNA Schadenssensor-Proteine, welche ihrerseits 
Checkpoint-Proteine aktivieren, die entweder den Zellzyklus anhalten, um die 
DNA Reparatur zu ermöglichen, oder, falls die Schäden zu massiv sind, die 
Zelle in den kontrollierten Zelltod, die Apopotose, führen. Die verschiedenen 
DNA Reparaturmechansimen auf der anderen Seite, versuchen den Schaden 
zu reparieren und im besten Fall die unveränderte DNA wieder herzustellen 
und dadurch genomische Instabilität zu verhindern. 
Das Ziel dieser Studie war es, verschiedene DNA Reparaturmechanismen in 
zwei verschiedenen Organismen, nämlich in Deinococcus radiodurans (D. 
radiodurans) und in menschlichen Zellen, zu untersuchen. Im ersten Teil 
dieser Dissertation wurden zwei vermeintliche DNA Ligasen von D. 
radiodurans bearbeitet, was zur biochemischen Charakterisierung einer 
NAD+-abhängigen DNA Ligase geführt hat. Es konnte gezeigt werden, dass 
die DNA Ligaseaktivität in der Gegenwart von 1mM MnCl2 am effizientisten 
war, wobei die Substitution von MnCl2 durch MgCl2 oder CaCl2 die 
Ligaseaktivität etwa um das zehnfache reduziert hat. Bei der zweiten, 
vermeintlich ATP-abhängigen DNA Ligase konnte keine Ligaseaktivität 
festgestellt werden, obwohl ein Adenylyltransferase Intermediat gebildet 
wurde. Im weiteren wurde die O6-methylguanin-DNA methyltransferase 
(MGMT) von D. radiodurans untersucht. Obwohl die Klonierung und die 
Reinigung erfolgreich waren, war die biochemische Charakterisierung nur 
bedingt möglich, da keine Methyltransferaseaktivität festgestellt werden 
konnte. Die Faltung des Proteins schien korrekt, da die MGMT an DNA 
binden konnte.  
Im zweiten Teil dieser Dissertation wurde die in unserem Labor beschriebene 
Interaktion zwischen dem Rad9/Rad1/Hus1-Komplex (9-1-1 Komplex) mit der 
apurinischen/apyrimidinischen Endonuklease 1 (Ape1) weiter untersucht. 
Durch den Gebrauch von Protein-Fragmenten konnte gezeigt werden, dass 
sich die Endonuklease Aktivität im N-terminalen Teil des Proteins befindet. 
4
4
4464
 5 
Weiter deuten die Erkenntnisse darauf hin, dass in der Interaktion zwischen 
dem 9-1-1 Komplex und Ape1 das komplette Ape1-Protein involviert ist. 
Schliesslich zeigen initiale Beobachtungen, dass der 9-1-1 Komplex auch mit 
der DNA-Polymerase ! interagiert, was bis dato nicht bekannt war. 
5
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2. Introduction 
2.1. Deinococcus radiodurans 
2.1.1. Characteristics of the radioresistant bacterium Deinococcus 
radiodurans 
Deinococcus radiodurans (D. radiodurans) is a non-motile, non spore-forming 
bacteria belonging to the genus of the Deinococcae. Due to its pigments it has 
a pink to almost orange color. It is considered as a gram-positive bacteria 
although it differs in the composition of its cell envelope, which is similar to 
gram-negative bacteria. D. radiodurans contains a thick peptidoglycan layer 
and an outer membrane, some strains also having paracrystalline S-
layers/lipid-composition of their cell wall and also have a different type of cell 
layers. The bacteria grow as chemoorganotrophic obligate aerob in rich 
media, whereby they reach their maximal generation time of 80 minutes when 
kept at 30°C. Growth only ceases with temperatures below 4°C and above 
45°C (reviewed in [1, 2]). 
D. radiodurans was discovered in 1956 in canned beef that was treated with 
what was supposed to be a sterilizing dose of ionizing radiation at that time 
[3]. Its genome however was only fully sequenced in 1999 [4]. It consists of 2 
chromosomes, 1 megaplasmid and a smaller plasmid, which all together 
encode for around 3200 proteins. The genome is present as multiple copies 
per cell, ranging from 4 to 10, which depends on the phase of the cell cycle [5, 
6]. Additionally, there were reports stating that the DNA forms a doughnut-
shaped, ring-like structure, but this observation is still under debate [7]. But 
what makes D. radiodurans such an extraordinary organism is that it is one of 
the most radioresistant bacteria known to date, exponentially growing cultures 
withstanding up to 15,000 Grays (Gy) of irradiation with a shoulder of 
resistance at around 5,000 Gy without loss of viability [8]. The average lethal 
dose of 50% for mammals is about 5 Gy. Even more astonishing are those 
numbers in the view that an ionizing radiation (IR) dose of 6,000 Gy leads to 
about 200 double-strand breaks, over 3000 single-strand breaks and over 
1,000 base damages [9-11]. This makes clear that there must be very 
sophisticated DNA repair pathways to deal with such high amounts of DNA 
6
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damages. Different models suggesting pathways that might explain the 
radioresistance have been proposed (reviewed in [7]): 
First, scientists considered mechanisms that would protect the D. radiodurans 
genome from the huge damage. Under discussion were the pigments, which 
also give the bacterium its color. But this theory was discarded soon 
thereafter, since no links were found between pigmentation and 
radioresistance. Then, another idea was put forward, based on the fact that D. 
radiodurans has high internal levels of Mn2+ and only low amounts of Fe2+. 
Also here, a connection to radioresistance was anticipated, assuming that the 
Mn2+ ions could somehow protect the DNA from heavy damages. But this 
approach had to be dismissed too, since there was experimental proof that 
the DNA of D. radiodurans was shattered into pieces as it is the case for the 
DNA of any other organism. However upon irradiation the DNA repair process 
seems to be very quick, reconstituting the whole genome within 3 hours of 
recovery. This moved the focus of curiosity away from passive protection 
mechanisms and towards very active DNA repair processes. 
Here too, rather passive aspects were considered first. It was proposed that 
the number of genome copies per cell was important. This is based on the 
assumption that having more than just one copy of the genome per cell 
facilitates the process of finding another stretch of homologous DNA. Thus, 
the repair enzymes can use this as a DNA matrix for the re-synthesis of the 
damaged or lost DNA parts. But, although this might indeed help to rebuild 
parts of the genome, it cannot be the only reason for this stunning 
radioresistance observed, as also Escherichia coli (E. coli), which is not 
considered to be specially resistant to IR nor to UV or other damaging agents, 
can also have multiple copies of its genome at some points of its growth. 
Next, an unusual form of D. radiodurans DNA was proposed for its ability to 
repair its genome fast and accurate. Based on the tight compaction of the 
DNA into ring-like structures, it would hamper broken DNA strands to fall apart 
and diffuse to distant sites of the cell. This could be beneficial for repair 
processes like homologous recombination. As mentioned before, this theory is 
now under debate, as the putative doughnut-shaped structure could not be 
confirmed when using another means of microscopy. However, latest findings 
suggest that the compaction of the genome is of importance as knock-out 
7
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strains for the histone-like, nucleoid-associated protein HU are lethal due to 
decompaction of the D. radiodurans genome (H. H. Nguyen, paper in press). 
Finally, another appealing possibility could be that D. radiodurans evolved 
new, additional repair enzymes, which are unique to this bacterium. After the 
full sequencing of the genome, researchers were disappointed to mainly find 
the common set of bacterial repair proteins with only a few so far unknown 
proteins. But up to now none of the new proteins has proven to be the one 
and only responsible for the extraordinary capabilities of D. radiodurans. 
Another approach which is most favored and sustained, suggests that D. 
radiodurans has a similar set of repair enzymes as do other bacteria, but that 
it evolved sophisticated ways to use these enzymes in a more efficient way. 
In favor for this thesis are recent findings highlighting a new mechanism, 
called “extended synthesis-dependent strand annealing” (ESDSA; Figure 1 
and [12, 13]). In these two articles the authors found that the previously 
described D. radiodurans DNA polymerase (pol) III and DNA pol I are involved 
in ESDSA, together with the recombinase A (RecA) and RadA proteins. In 
general, DNA pol III seems to be the main polymerase, which is essential for 
global DNA synthesis, at least under normal growth conditions, whereas DNA 
pol I seems to contribute to the survival potential, probably due to is potential 
involvement in base excision repair (BER) pathways. RecA seems to play an 
essential role in promoting degradation of DNA ends as well as DNA 
synthesis priming after recession. RadA is believed to play an additional role 
in priming, but only when RecA is present; in the absence of RecA, RadA 
seems to work in another pathway. It is proposed that in ESDSA, the 
shattered chromosomal fragments are first extensively degraded by 
exonucleases such as RecA and RadA. This leads to single-stranded 
overhangs, which can work as templates as well as primers for the 
subsequent massive DNA synthesis, which is observed after a 1.5 hr period of 
degradation. In this synthesis, “patchworks” of DNA fragments are built up, 
consisting of “old” DNA stretches (which existed before irradiation and act as 
primers), as well as newly synthesized DNA parts. This synthesis is primed by 
the recessed, single-stranded overhangs, which invade overlapping single- or 
double-stranded (via D-loop formation) templates. This normally involves 
RecA-like activities, which is confirmed by the fact that RecA deficiency 
8
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impedes DNA synthesis. DNA pol III is essential for the initiation of this repair 
synthesis, whereas both DNA pols I and III are required for subsequent 
efficient elongation. The third Deinococcal DNA pol, DNA pol XDr seems not to 
be involved in this process. This is corroborated by the fact that deletion of 
DNA pol XDr does not lead to increased radiation sensitivity although showing 
a reduced rate of repair of double-strand breaks [14]. After this DNA synthesis 
step, ESDSA is accomplished by the RecA-dependent inter- and 
intramolecular crossovers to process these longer or shorter DNA stretches 
into single-unit sized, circular chromosomes. 
   
Figure 1. Two alternative two-step processes of reassembling shattered 
chromosomes. A) The multiple copies of the genome of D. radiodurans are 
randomly shattered into pieces of double-stranded DNA. The ends are then 
recessed, most probably by exonucleases (1). Then, one of two possible events can 
occur: either the recessed ends work as primers and templates in ESDSA (2), giving 
rise to newly synthesized single-stranded DNA, probably through a moving D-loop. 
9
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These newly synthesized single-stranded overhangs can engage in several rounds 
of extension until they find a complementary partner strand (3). The base pairing of 
complementary strands occurs (4), which is further processed into linear double-
stranded DNA. A similar outcome is achieved by SSA, wherein the recessed DNA 
ends can rejoin directly through the annealing of complementary single-stranded 
overhangs of overlapping fragments from different chromosomal copies, thereby 
generating short gaps, which are filled in by the action of a DNA polymerase. B) The 
linear stretches of double-stranded DNA are then processed into circular plasmids 
via homologous recombination. DSB: double-strand breaks; SSA: single-strand 
annealing; ESDSA: extended synthesis-dependent strand annealing; HR: 
homologous recombination. Reproduced from Zahradka et al., Nature (2006) 443, 
569-73. 
 
Recently, another new opinion was put forward. Daly suggested that the high 
Mn2+ and low Fe2+ could have a beneficial effect towards the protection of 
proteins rather than the DNA itself. He argues that a cell needs functional 
enzymes first, before it can start repairing the shattered genome and that also 
proteins are targets of free radicals that are produced upon radiation [15]. 
In summary, the current opinion is that it is most probably not one trait that 
accounts for D. radiodurans’ amazing radioresistance but that it is a 
combination of several pathways and peculiar properties that render D. 
radiodurans so radioresistant. 
 
2.1.2. DNA Ligases 
DNA ligases are a very important class of enzymes, not only involved in DNA 
replication but also in DNA recombination and DNA repair. Their importance is 
further underscored by the fact that they are essential [16]. Additionally, they 
exist in all three kingdoms of life, bacteria, archaea and eukaryotes [17]. 
Bacterial ligases mainly use NAD+ as a cofactor, whereas eukaryotic, viral 
and archaeal enzymes use ATP as nucleoside monophosphate donor [18], 
thus being termed NAD+-dependent and ATP-dependent DNA ligase, 
respectively [19]. Recent data, however, state additional ATP-dependent 
ligases in bacteria, pointing into the direction that also prokaryotes have 
evolved different ligases for different tasks, as it is the case for eukaryotes. D. 
radiodurans is one of the examples where, in addition to a common bacterial 
NAD+-dependent DNA ligase, also an ATP-dependent DNA ligase has been 
predicted from the DNA sequence [20]. 
10
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Despite their different requirements concerning the co-factors used, the 
catalytic mechanism is conserved amongst the different classes of DNA 
ligases. Also the 4 distinct domains with several protein folds like a zinc (Zn)-
finger, an oligomer-binding (OB) "-barrel, a helix-hairpin-helix (HhH) motif and 
the BRCA1 C-terminus (BRCT) domain are conserved to different degrees 
amongst the species but also in between the kingdoms [17, 19, 21]. 
 
  
 
  
Figure 2. Domain structure of DNA ligases. A) Schematic representation of four 
different DNA ligases from Thermus filiformis (Tfi), Bacillus stearothermophilus (Bst), 
Bacteriophage T7 (T7) and Chlorella virus PBCV-1. Blue: subdomain 1a, green: 
adenylation domain, red: oligomer-binding (OB) fold, yellow: subdomain 3a (Zn-
Finger), orange: subdomain 3b, Helix-hairpin-Helix (HhH) motif, pink: BRCA1 C-
terminus (BRCT) domain. B) Ribbon diagrams for the four DNA ligases from A). 
11
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Colors are as in A). Reproduced from Doherty et al., Nucl. Acids Res. (2000) 28, 
4051-8. 
 
The involvement of all the DNA ligases in the processes mentioned above 
consist in their ability to covalently rejoin DNA ends by forming a phospho-
diesterbond between a 3`-hydroxyl and a 5`-phosphate of the DNA-backbone. 
This is achieved by three successive, but distinctive catalytic steps, involving 
two covalent intermediates (Figure 3). In step one, the enzyme itself is 
adenylated via a #-aminolysyl phosphoramidate bond, using either ATP or 
NAD+ as donor. In step two, the nucleotidyl moiety is transferred from the 
enzyme onto the 5`-phosphate end of the nick, thereby activating the 
5`terminus for the attack of the 3`-hydroxyl in the third step, which restores the 
phosphodiester bond between the two separated strands of DNA, thereby 
sealing the nick [19, 22].  
 
   
Figure 3. Ligation mechanism of bacterial DNA ligases. A) The amino-group of 
the catalytic lysine reacts with NAD+ or ATP, thereby leading to a phosphoamide-
linked AMP. B) In a next step, the 5’-phosphate at the nick attacks the activated 
phosphoryl group of the AMP, leading to an adenylated DNA. C) In the last step, the 
3’-OH-group of the DNA at the nick attacks the activated phosphate at the 5’, thereby 
12
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forming a phospodiester bond, thus sealing the nick and liberating the DNA ligase 
and the AMP. Reproduced from Wilkinson et al., Mol Microbiol (2001) 40, 1241-8. 
 
2.1.3. O6-methylguanine-DNA methyltransferase (MGMT) 
Besides damages that target the DNA backbone and thereby lead to DNA 
strand breaks, there are also endogenous as well as exogenous factors that 
alter the structure of DNA bases. One example for this are alkylating agents 
which are also used as anti-cancer drugs [23-26]. One lesion that is produced 
is O6-methylguanine. This base-substitution has a high mutagenic and 
cytotoxic potential, as the O6-methylguanine will frequently mispair with a 
thymine instead of a cytosine in the next replication round, thus leading to a 
G-C $ A-T transition mutation. Even if the mispairing is recognized by the 
mismatch repair machinery, the wrongly base paired thymine will be excised, 
leaving behind the altered O6-methylguanine, which might again recruit a 
thymine instead of the correct cytosine, which then again attracts the 
mismatch repair proteins. As a consequence, the futile mismatch repair might 
lead into apoptosis ([27, 28]; reviewed in [29]). 
Besides the mismatch repair system that is making an attempt to repair those 
lesions, the cell evolved specialized proteins that are responsible for removing 
the different alkyl-adducts. The one dedicated to O6-methylguanine is called 
O6-methylguanine-DNA methyltransferase (MGMT). It exists in all three 
kingdoms of life and despite the low primary sequence similarity found 
amongst the members of this protein family, the overall domain structure is 
nearly the same, with structural motifs involved in DNA recognition, substrate 
binding and selectivity of the alkyltransfer mechanisms (reviewed in [30]). 
The human MGMT is 22 kDa in size and ubiquitously expressed in normal 
tissues. It can be phosphorylated and ubiquitinated and may function in 
transcription regulation, cell cycle control and apoptotic signaling (reviewed in 
[31] and [32]). MGMT-mediated repair is unique compared to other repair 
pathways in four different aspects [32, 33]:  
• MGMT acts alone, without another protein or a co-factor. 
• it binds the alkyl group covalently to an internal cystein and therefore 
acts as a transferase enzyme as well as an acceptor protein. 
• it is inactivated through this action. 
13
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• repair occurs in a stoichiometric fashion, which can easily lead to 
saturation if the DNA-adducts are occuring in excess. 
The last three points highlight the unique feature of this protein, which cannot 
turn over, because the bond between the transferred methyl group and the 
acceptor cysteine, which resides in a highly conserved motif, is extremely 
stable. It is therefore often referred to as “suicidal” or “kamikaze” protein. Said 
that, it is clear that any substrate for the protein acts also as an irreversible 
inhibitor. Bearing this in mind, it seems reasonable that mice lacking MGMT 
are viable and show no obvious phenotypes unless they are treated with 
alkylating agents [34, 35]. Also, cells that have lost the MGMT-activity due to 
promoter hypermethylation or mutations in the MGMT gene are sensitized to 
the killing effects of alkylating agents [36-38], but this in turn can be 
attenuated by the additional loss of the mismatch repair system (MMR), as 
then, no futile attempt to repair the O6-guanine-thymine mismatch is 
undertaken, thus preventing induction of apoptosis [39-42]. 
 
   
Figure 4. Mechanism of action of O6-methylguanine-DNA methyltransferase 
(MGMT). In the transferase proficient state, the cysteine in the active site is 
unmethylated. It then reacts with the methyl-group of the O6-methylguanine, 
whereby the methyl group is covalently attached to the MGMT. The MGMT cannot 
be recycled after this and is therefore degraded by the ubiquitin-dependent 
proteasomal pathway. Reproduced from Hegi et al., J. Clinic. Oncol. (2008) 26, 
4189-99. 
2.2. DNA damage response 
Cells suffer from a plethora of different assaults on its genome every day. 
DNA damaging agents are produced endogenously as products of normal 
14
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cellular metabolism, e.g. reactive oxygen species like superoxide anions, 
hydroxyl radicals or also hydrogen peroxide, which are products of oxidative 
respiration and lipid peroxidation occurring in the cell. Also do some chemical 
bonds in the DNA tend to spontaneously disintegrate under physiological 
conditions, leading to abasic sites or, in the case of spontaneous or induced 
deamination of bases, give rise to miscoding bases such as uracil (from 
cytosine), hypoxanthine (from adenine), xanthine (from guanine) and thymine 
(from 5’-methyl cytosine). There are also exogenous sources of DNA 
damages e.g. IR, UV radiation and environmental toxins (e.g. from tobacco 
smoke), as well as chemical agents used in chemotherapeutics (reviewed in 
[43]). The resulting DNA damages may be simple base alterations but they 
may also include DNA backbone damages such as single- and double-strand 
breaks or even DNA interstrand cross-links as well as DNA-protein cross-
links. 
The cell evolved different damage response reactions to counteract these 
lesions (reviewed in [44]): 
• removal of the lesion and restoration of the continuity of the DNA 
duplex by different repair pathways, 
• activation of DNA damage checkpoints, which leads to an arrest in the 
cell cycle, allowing the cell to repair damaged or incompletely 
replicated chromosomes, 
• induction of transcriptional responses which cause changes in the 
transcription profile of the cell, 
• and ultimately, in case of extensive DNA damage, induction of 
apoptosis. 
For removal of the lesion, the cell has evolved highly sophisticated repair 
pathways, all specialized in one or a few kinds of damages. 
Small chemical alterations are, if they are not repaired in a direct repair 
mechanism as it is the case for O6-methylguanine and MGMT, mostly 
targeted by base excision repair (BER). Mispaired nucleotides, as well as 
insertions and deletions are removed via the mismatch repair (MMR) 
pathway. Nucleotide excision repair (NER) concentrates on a wide class of 
helix-distorting lesions that interfere with base pairing as well as with 
transcription and replication. For DNA double-strand breaks bacteria 
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preferentially use homologous recombination (HR), whereas in mammalian 
cells more than 90% of double-strand breaks are repaired by non-homologous 
end-joining (NHEJ) (reviewed [43-47]). 
 
2.2.1. Base Excision Repair (BER) 
2.2.1.1. Overview 
As depicted in Figure 4, BER is initiated by glycosylases that release the 
damaged base, thereby forming an abasic site (AP), although these sites can 
also be formed as a direct damage product, for example through spontaneous 
base loss. The glycosylases are lesion specific. Some are simple or 
monofunctional glycosylases and hydrolyse the N-glycosidic bond, leaving 
behind an abasic site with an intact phosphodiester bond. Bifunctional 
glycosylases not only excise the damaged base but also incise the backbone 
3` to the AP-site in an "- or ", %-elimination reaction, leading to a single-strand 
break in the DNA backbone and to a 3`-&, " unsaturated aldehyde or a 3`-
phosphate, which is turned into a normal 3`OH-group by apurinic/apyrimidinic 
endonuclease 1 (Ape1) or polynucleotide kinase (PNKP), respectively. Ape1 
then incises 5` to the AP-site. Finally, DNA pol " replaces the damaged 
nucleotide and DNA ligase III& (lig III&), in a complex with X-ray repair cross-
complementing group 1 (XRCC1), can ligate the nick. This is the case for the 
so-called short-patch (SP-) BER, because DNA pol " only fills in one single 
nucleotide [48-51]. 
There is also a second, so-called long-patch (LP-) BER, which is particularly 
used when the 5`-moiety is refractory to the DNA pol " AP-lyase excision 
activity. In this case, strand displacement synthesis occurs using the 
proliferating cell nuclear antigen (PCNA)-dependent DNA pols # or %, together 
with the loading enzyme replication factor C (RF-C), replacing a 2-12 
nucleotide long strand. The so created flap-structure is then cut by flap 
endonuclease 1 (Fen1) and the resulting nick is sealed by DNA ligase I ([52, 
53], reviewed in [54, 55]). 
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Figure 4. Schematic representation of the known base excision repair (BER) 
sub-pathways. BER is induced by a damaged base, which is recognized either by a 
mono- or a bifunctional glycosylase. After simple removal (monofunctional 
glycosylases) Ape1 processes the 5’-end making it available for DNA pol ". In case 
of bifunctional glycosylases Ape1 activity is not necessarily needed, as these 
glycosylases process the 5’-ends themselves. After processing of the 3’-end, one of 
two sub-pathways is chosen, depending on the biochemical structure of the 5’-end at 
the lesion. Either long-patch (LP-) BER is chosen, wherein DNA pols % or ", together 
with proliferating cell nuclear antigen (PCNA) and replication factor C (RF-C) can 
perform strand displacement synthesis, generating a flap of two to ten nucleotides, 
which is subsequently removed by flap endonucease 1 (Fen1). The nick is finally 
sealed by DNA ligase I. In short-patch (SP-) BER, DNA pol " synthesizes only one 
nucleotide. The 5’-phosphate is available for sealing the nick by DNA ligase III, 
therefore the action of Fen1 is refractory. Reproduced from Hedge et al., Cell Res. 
(2008) 18, 27-47. 
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2.2.1.2. Apurinic/apyriminidic endonulcease 1 (Ape1) 
Apurinic/apyrimidinic endonuclease 1/redox effector factor-1 (Ape1/ref-1) is 
the major AP endonuclease in mammalian cells. Besides its function in BER, 
it also works as a redox factor, keeping transcription factors in a reduced, 
active state. It is also involved in the in vivo activation of bioreductive drugs 
through reduction. Furthermore, it stimulates DNA-binding of important 
transcription factors such as e.g. Fos, Jun, NF'B, HIF-1& or p53 [56-61]. 
Additionally, it acts as a negative regulator of the parathyroid hormone 
promoter and is part of the HREBP-transcription factor complex. In line with 
these important functions is the finding, that mice nullizygous are embryonic 
lethal [62-64]. 
AP endonucleases are classified into 2 families, according to their homology 
to the E.coli exonuclease III (xth) and endonuclease IV (nfo) [65]. Human 
Ape1 belongs to the Exo III-family, together with mouse APEX or Drosophila 
RrpI. This enzyme class is characterized by its strong AP hydrolytic activity 
and an additional 3`-diesterase activity. 
Although there is only about 25-40% sequence identity between the human 
Ape1/Ref-1 and its prokaryotic homologs, there is a high degree of homology 
amongst the mammalian AP-endonucleases on the protein-level (reviewed in 
[65]). Human Ape1/Ref-1 is a 2.6kb gene, coding for 5 exons (whereof the 
first is non-coding) separated by 4 introns. These are translated into 318 
amino acids, which gives rise to a 37kD protein, consisting of 2 domains, each 
of which is made up of a 6-stranded "-sheet, surrounded by &-helices, 
thereby forming a 4-layered &/"-sandwich [65-70]. 
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Figure 5. Christal structure of Ape1 bound to DNA. Reproduced from Wilson et 
al., Nat Struct Biol (2000) 7,176-8. 
 
Different residues responsible for substrate recognition, Mg2+ positioning and 
building up of the active site nucleophil have been identified [69, 71]. 
The expression profile of Ape1/Ref-1 is complex and heterogenous, differing 
among tissue types and even between neighboring cells, which may be 
explained by its multifunctional roles in the cell [66, 72-74]. In some cell types, 
it is solely found in the nucleus, sometimes in association with chromatin (e.g. 
in the cerebellum), sometimes not (e.g. in epidermal cells), whereas in other 
cells, it is cytoplasmatically localized (e.g. in macrophages or spermatozytes), 
but again other cells show nuclear as well as cytoplasmatic staining (e.g. in 
adrenal cortical cells) (reviewed in [65]). 
Ape1/Ref-1 is regulated at the transcriptional as well as at the post-
translational level. Translational regulation includes induction by oxidative 
agents, which transiently increase the mRNA and protein level due to de novo 
synthesis, thereby increasing the cells` resistance to killing by H2O2, MMS 
and other genotoxic agents. 
Post-translational modifications are mainly manifested in phosphorylation of 
different residues, but the effects of these are not fully understood yet but 
seem to be dependent on the type and site (amino acid residue) of the 
modification. Furthermore, Ape1/Ref-1 is acetylated by p300, which has yet to 
be linked to a modulation of the repair capacity, but appears to be linked to its 
redox potential exclusively (reviewed in [48]). 
Last but not least, Ape1/Ref-1 is reduced by thioredoxin (TRX), thereby 
enhancing the sequence specific binding of AP-1 and p53, which is mediated 
through Ape1/Ref-1. 
This underscores the important involvement of Ape1/Ref-1 in processes like 
DNA repair, cell cycle control, apoptosis, angiogenesis, cellular growth and 
differentiation, neuronal excitation, hematopoiesis and development (reviewed 
in [65]). 
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2.2.2. Cell cycle checkpoint 
2.2.2.1. Overview 
Cells are challenged with a variety of DNA damages every day. To counteract 
the detrimental effects of these endogenous and exogenous insults, the cells 
have evolved elaborate mechanisms to ensure genomic stability. One 
damage response mechanism is the initiation of cell cycle checkpoints. DNA 
damage checkpoints were first defined as non-essential regulatory pathways 
that control the ability of cells to arrest the cell cycle in response to DNA 
damage, allowing time for DNA repair (reviewed in [75]). However, this 
definition is too simple. Emerging evidence suggests that these pathways are 
additionally involved in the control of DNA repair pathways, the composition of 
telomeric chromatin and the movement of repair proteins to sites of damage, 
activation of transcriptional programs, telomere length and, induction of 
apoptosis. Cell cycle checkpoints have been identified at the G1/S and G2/M 
boundaries, as well as during the S phase and potentially also in mitosis. 
The signal transduction in checkpoint response is thought to be organized into 
sensors, which recognize the DNA damage, mediators and transducers, 
which mediate and transmit the signal to the effectors, which then in turn 
ultimately trigger the different responses to the damages [76]. 
In general, two main pathways can be distinguished, although they may 
interact at various stages: 
(i) Replication stress and other single-strand generating DNA damages like 
UV irradiation induce the phosphorylation of checkpoint kinase 1 (Chk1) by 
Ataxia telangiectasia and Rad3 related kinase (ATR). Activated Chk1 
stabilizes stalled replication forks, blocks the firing of late replication origins 
and arrests cells in the G2 to M phase. 
(ii) Double-strand breaks, for example induced through IR, are believed to 
trigger Ataxia telangiectasia mutated kinase (ATM) activation, which in turn 
phosphorylates checkpoint kinase 2 (Chk2). This leads, amongst other 
outcomes, to phosphorylation of p53, which, via transcriptional activation of 
p21, prevents the entry from G1 into S phase of the cell cycle. 
In spite of the simplified view presented above, G2/M arrest most likely 
functions via an interplay between the transducer kinases Chk1 and Chk2. 
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Furthermore, abolishment of G2/M arrest is mediated by another class of 
proteins, namely the Cell division cycle phosphatases (Cdc25), which are 
themselves phosphorylation targets of Chk1 and Chk2 and are required to 
remove the inhibitory Cyclin dependent kinase (Ckd) phosphorylation, thereby 
allowing progression from G2 into mitosis (reviewed in [76, 77]). 
The Rad9/Rad1/Hus1 (9-1-1) complex was originally found in genetic screens 
for sensitivity to genotoxins. The complex was found to be targeted to the 
nucleus and to DNA damage sites after genotoxic stress, implicating a role in 
DNA damage recognition ([78] and reviewed in [77]). Further insights came 
then from molecular modeling, reveilling a structural resemblance to PCNA, a 
doughnut-shaped homotrimeric clamp, which is loaded around DNA at sites of 
replication, serving as a sliding platform to tether replication proteins to the 
DNA [79-87]. Additional studies found that ATM-mediated phosphorylation of 
Rad9 was necessary for IR-induced checkpoint activation and that loading of 
the 9-1-1 complex to the damaged sites affects the target specificity of ATR, 
thereby further highlighting a role in sensing DNA damage and also 
implicating a role in the activation of checkpoint signaling pathways [88]. 
Furthermore, the alternative clamp loader, Rad17-RFC2-5, known to be 
important for efficient loading of the 9-1-1 complex to damaged sites, was 
shown to be critical, as disruption of phosphorylation of Rad17 by ATM and 
ATR relieved G2 arrest, thereby leading to an increased sensitivity upon 
genotoxic stress [89]. 
Growing evidence suggests that the 9-1-1 complex not only acts as a sensor 
of DNA damage, but is also involved in DNA damage repair. It was shown that 
the 9-1-1 complex interacts with and stimulates various BER components [90-
98]. 
Taken together, the 9-1-1 complex appears to not only mediate proper 
checkpoint activation and signaling through ATM and ATR, but it can also 
stimulate conventional DNA repair pathways, thereby providing an unique link 
between cell cycle checkpoints on one hand and repair pathways on the other 
hand. 
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2.2.2.2. Structure of the 9-1-1 complex 
The three human proteins Rad9, Rad1 and Hus1 form a heterotrimeric 
complex, the 9-1-1 complex. The single subunits interact in a head-to-tail 
fashion comparable to PCNA, giving rise to a ring-shaped, 110 kDa sized 
protein-complex, which is 10 +/- 2 nm in diameter and has a hole of 2-3 nm in 
its middle ([99] and Figure 6). 
 
    
Figure 6. Structure of the Rad9/Rad1/Hus1 (9-1-1) clamp and topography of the 
interactions with the subunits of the checkpoint clamp loader, Rad17-RF-C2-5 
complex. The white arrows indicate the interaction sites with Rad17-RF-C2-5 
subunits. Reproduced form Venclovas et al., Protein Sci. (2002) 11, 2403-16. 
 
Rad1 and Hus1 together build a pre-complex in the cytoplasm before 
associating with Rad9 and being translocated to the nucleus through the NLS 
residing in the C-terminal end of Rad9 [79, 82, 85, 100]. Through this 
controlled transport from the cytoplasm to the nucleus a sort of quality control 
is achieved, as for the integrity and also functionality of the complex, all three 
subunits are needed [101]. Furthermore, it was found that in Hus1-/- mouse 
embryonic fibroblasts (MEFs) the levels of Rad9 decreased and that Rad9 
localized exclusively in the cytoplasm, indicating that transport of Rad9 is also 
dependent on the presence of Hus1 [101]. The finding that the entire complex 
is likely necessary for translocation into the nucleus was further underscored 
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in fission yeast, where nuclear localization was also dependent on Rad9 as 
well as on Rad1 [80]. 
 
2.2.2.3. Rad9 
The human Rad9 consists of 391 amino acids giving rise to a protein of 43 
kDa. It shares 25% identity and 52% similarity with the Schizosaccharomyces 
pombe (S. pombe) Rad9 protein, which is consistend with the finding that the 
human protein can at least partially complement the radiosensitivity of a yeast 
Rad9 null mutant [102]. 
Rad9 is a nuclear protein that exerts a multitude of cellular processes as for 
example the mediation of G2/M and S-phase checkpoint activations through 
the regulation of phosphorylation of Rad17, Chk1, Chk2 and others upon 
replication block and DNA damage [78, 87, 103]. Additionally, it is thought to 
be a critical player in chromosomal stability and integrity as knock-out cells 
display an increased frequency of chromosomal abnormalities. Furthermore, 
Rad9-/- mice are embryonic lethal [103, 104]. 
Over ten phosphorylation sites have been mapped in the 110-amino acid C-
terminal domain, some of which are required for phosphorylation of Chk1 and 
interaction with DNA topoisomerase II binding protein 1 (TopBP1). In contrary, 
the 110-amino acid domain is not required for the interaction with Rad1 or 
Hus1 [87, 88]. 
 
2.2.2.4. Rad1 
Human Rad1 is a 283 amino acids protein. It is 32 kDa in size and predicted 
to be highly acidic. Like the human Rad9 protein, it is highly conserved, 
demonstrated by 31% identity and 42.6% similarity to the S. pombe Rad1 
protein. It exists in three different variants, Rad1-a being the largest; Rad1-b 
contains an in-frame stop codon in the middle of the Rad1-a open reading 
frame, resulting in the deletion of nucleotides 199 through to 307. The third 
variant is missing residues -59 through to 21 of Rad1-a, which eliminates the 
putative translation start codon of Rad1-a [105]. Rad1-a shows 3` to 
5`exonuclease activity, which is not seen with the two other Rad1 forms. 
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Loss of Rad1 in vivo leads to a destabilization of Rad9 and Hus1. Disruption 
of the 9-1-1 complex leads to major defects in S-phase control, as well as 
chromosomal abnormalities and radioresistant DNA synthesis. Furthermore, 
in cells depleted for Rad1 the ATR-dependent Chk1 activation is impaired, but 
not the one of Chk2, mediated by ATM [106]. 
 
2.2.2.5. Hus1 
Mammalian Hus1 is 31 kDa in size, consisting of 280 amino acids, which 
confer a 30% identity to the S. pombe. It is expressed throughout embryonic 
development, which is also mirrored in the embryonic lethality of Hus1-/- mice 
[107, 108]. Hus1 is rapidly degraded in the cytoplasm via the ubiquitin-
proteosomal pathway if it is not in a heterodimeric pre-complex with Rad1, 
thereby being stabilized. In Xenopus leavis egg extracts as well as in S. 
pombe ATR-dependent phosphorylation of Hus1 is observed [109]. 
Furthermore, in Hus1 knock-out MEFs, abrogated checkpoint response to UV 
irradiation was observed along with replication blocks, increased apoptosis, 
increased frequency of chromosomal abnormalities and S-phase specific 
accumulation of phosphorylated H2AX, which is a marker for double-strand 
breaks in DNA [107, 108]. 
 
2.2.3. DNA polymerase !  
DNA polymerases are template-directed machines for the phosphoryl transfer, 
which are needed to build up long polymers of nucleotide monophosphates in 
DNA replication and repair. Since the discovery of the first eukaryotic DNA pol 
& in 1957 the number of eukaryotic polymerases has grown to about 20 
known DNA pols today, which were all classified according to their primary 
sequence, giving rise to the DNA pol families A, B, X, Y and RT. DNA pol ! 
belongs, together with DNA pol ", terminal deoxyribonucleotidyl transferase 
(TdT), DNA pol µ and the African swine fever virus DNA pol to the DNA pol X 
family [110]. 
DNA pol ! is a single-subunit enzyme, lacking a 3`$5` exonuclease activity 
(Figure 7). The human 575 amino acids enzyme consists of an N-terminal 
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BRCT domain, important for protein-protein interactions, a serine-proline rich 
region, which is involved in post-translational modifications of the enzyme 
[111], as well as a 39kDa catalytic core, which shares 33% amino acid 
similarity with the catalytic core of DNA pol " [112]. Furthermore, the catalytic 
core can be subdivided into an N-terminally located 8kDa domain, containing 
the dRP lyase activity and the polymerase domain, which itself again is further 
subdivided using the terminology of a human right hand [113]; the fingers 
domain includes important residues for interaction with the incoming 
deoxyribonucleoside triphosphates as well as for the template base to which it 
is paired. The thumb may play a role in positioning the duplex DNA and in 
processivity and translocation. The palm finally contains the catalytic 
carboxylates [112]. 
 
   
Figure 7. Structure of the human DNA polymerase !. A) Schematic 
representation of the domain structure of DNA pol !. Grey: BRCA1 C-terminus 
(BRCT) domain and serine-proline (SP) domain, violet: 8kDa domain, blue: fingers 
domain, red: palm domain, green: thumb domain. B) Ribbon diagram of DNA pol ! in 
contact with DNA, representing the spatial distribution. Color code is as in A). 
Reproduced from Garcia-Diaz et al., DNA Repair (2005) 4, 1358-67. 
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Unlike for DNA pol ", the fingers and thumb domain of DNA pol ! do not 
switch from an open to a closed conformation upon dNTP binding; rather DNA 
pol ! is in a closed conformation (and therefore in an active state) also before 
dNTP binding [114]. This implicates that catalysis only depends on the correct 
positioning of the substrate. The discrimination between correct and incorrect 
insertion is likely related to subtle conformational changes in the active site. 
Additionally, interactions with the minor groove of DNA could contribute to 
nucleotide selectivity; base damage or also non-Watson Crick base pairs 
might result in a non-catalytical positioning of the 3`-O or the &-phosphate, 
thereby preventing catalysis. 
Nonetheless, DNA pol ! has an unusually low fidelity and an unique error 
specificity; its average single base deletion error rate exceeds its average 
single base substitution error rate [112]. This might be in relation to its ability 
to use template-primer with limited base pair homology at the primer terminus, 
which is the case in NHEJ where DNA pol ! seems to play a crucial role. In 
favor for this would also be the fact that DNA pol ! has a dRP lyase activity, 
which can remove blocking 5`-terminal sugar phosphate (dRP) groups. 
Besides its supposed function in NHEJ, DNA pol ! is also involved in BER. 
Studies carried out in our laboratory suggested important roles of RP-A in 
helping DNA pol ! to faithfully act: RP-A, together with PCNA, can suppress 
completely the deoxyribonucleotidyltransferase activity of DNA pol !, while 
stimulating its polymerase activity [115]. RP-A, but not PCNA, selectively 
prevents the misincorporation of an incorrect nucleotide by DNA pol !, without 
affecting correct incorporation [116]. RP-A and PCNA thus allowed the correct 
incorporation of dCTP opposite a template 8-oxo-G by DNA pol ! 1200-fold 
more efficiently than incorrect dATP. Furthermore, RP-A and PCNA enhance 
the fidelity of translesion synthesis of 2-OH-A in a repeated sequence by DNA 
pol ! [117]. RP-A and PCNA can therefore act as molecular switches to 
activate the DNA pol !-dependent highly efficient and faithful repair of A:8-
oxo-G mismatches in human cells, while they inhibit the less faithful DNA pol 
" thus coordinating the DNA polymerase selection in 8-oxo-guanine repair 
[118]. Taken together, These findings suggested for the first time a novel 
accurate mechanism to reduce the deleterious consequences of oxidative 
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damage and, in addition, point to an important role for RP-A and PCNA in 
determining a functional hierarchy among different DNA pols in the lesion 
bypass of 8-oxo-G [119].  
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3. Aim 
The aim of this thesis was to characterize four different DNA repair proteins. 
In the first part, two DNA repair enzymes of the radiationresistant bacterium 
D. radiodurans should be studied and biochemically characterized, being first, 
two putative DNA-ligases and second a methyl guanine methyltransferase. 
In the second part, two enzymes involved in human DNA repair were studied, 
being first the interaction between the 9-1-1 complex and Ape1 and its 
fragments, and second, an interaction between the 9-1-1 complex and DNA 
pol !. 
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4. Materials and Methods 
4.1. Chemicals 
Protein G beads were from Amersham Biosciences. Anti-HA beads were from 
Sigma. All other reagents were of analytical grade and were purchased from 
Merck or Fluka. Primers were from Microsynth. 
 
4.2. Proteins and Antibodies 
Bovine serum albumin (BSA) was purchased from New England Biolabs. 
Human MGMT was from Sigma or Alexis (see Results). The human His-
Rad9-1-1 complex was purified as described [96]. DNA pol ! was expressed 
and purified as described [120]. Anti-DNA pol! and anti-Ape1 antibodies were 
raised in rabbits against the recombinant wild-type proteins by standard 
methods. Anti-DNA pol " antibody was from Thermo. Anti-His antibody was 
from Qiagen. Anti-Rad9 antibody was a gift from R. Freire (Teneriffe, Spain), 
anti-Rad1 antibody, together with the anti-Hus1 antibody was from Santa Cruz 
Biotechnology. Secondary anti-mouse and anti-rabbit antibodies were from 
Amersham biotechnology. Anti-goat antibody was from Santa Cruz 
Biotechnology. 
 
4.3. Buffers and Solutions 
Coomassie stain    Coomassie destain 
0.25% (w/v) Coomassie blue R250 10% (v/v) acetic acid 
40% (v/v) methanol    10% (v/v) isopropanol 
10% (v/v) acetic acid 
 
EDTA (0.5M, pH 8.0) 
Dissolve 186.1g EDTA (disodium salt) in 800ml H2O 
While stirring, gradually add 20g NaOH 
Adjust with ddH2O to 950ml 
Adjust pH to 8.0 using 1.0 M NaOH 
Adjust with ddH2O to 1 l 
(autoclave) 
 
DNA loading buffer (10x, for agarose gels) 
50% (v/v) glycerol 
50mM Tris/HCl, pH 7.5 
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20mM EDTA 
0.1-0.2% Bromophenol blue 
0.1-0.2% Xylene cyanol 
if needed add 5µl of 5mg/ml Ethidium bromide to the DNA loading buffer 
 
Ethidium bromide    TAE (10x) 
50mg Ethidium bromide   400mM Tris base 
dissolve in 10ml H2O   10mM EDTA 
use 10µl per 100ml agarose solution 11.5ml glacial acetic acid 
      adjust to pH 8.0 
 
Hybridization buffer (10x)  TBE (10x) 
300mM Tris/HCl, pH 7.5   900mM Tris base 
500mM NaCl     900mM Boric acid 
10mM EDTA     20mM EDTA 
 
DNA polymerase !  buffer (10x) Stop buffer (PAA gels) 
500mM Tris/HCl, pH 7.5   96% Formamide 
500mM NaCl     20mM EDTA 
10mM "-mercaptoethanol   0.02% Bromophenol blue 
      0.02% Xylene cyanol 
 
Laemmli buffer (4x)   TBST (10x) 
500mM Tris/HCl, pH 7.5   10mM Tris/HCl, pH 7.5 
4% (w/v) SDS    150mM NaCl 
20% (v/v) glycerol    0.1% (v/v) Tween 20 
40mM DTT 
0.02% (w/v) Bromophenol blue 
 
Resolving gel buffer   Stacking gel buffer  
for SDS-PAGE    for SDS-PAGE 
1.5M Tris base    0.5M Tris base 
0.4% (w/v) SDS    0.4% (w/v) SDS 
adjust to pH 8.8 with HCl   adjust to pH 6.8 with HCl 
 
Running buffer    Transfer buffer 
for SDS PAGE (5x)    for SDS PAGE 
125mM Tris/HCl, pH 7.5   25mM Tris/HCl, pH 7.5 
1M glycine     150mM glycine 
0.5% (w/v) SDS    20% (v/v) Methanol 
 
Dilution Buffer Ape1   dRP-Lyase Buffer (10x) 
25mM Tris/HCl, pH 7.5   500mM Tris/HCl, pH 7.5 
2.5mM ß-Mercaptoethanol   200mM KCl 
75mM NaCl     20mM DTT 
15% glycerol     5mM MgCl2 
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4.4. Western blot analysis 
Proteins were separated on a 15% SDS-PAGE gel (40% stock solution 
Acrylamide/Bis, solution (37.5:1), (Serva)) and electroblotted for 1.5h at 
100V, (BioRad Western Blot apparatus) onto nitrocellulose membran 
(Immobilon) in transfer buffer at 4°C. After blocking the membranes for 60min 
in TBST containing 2.5% ( w / v )  powdered milk, the membranes were 
incubated with the appropriate antibodies, diluted in TBST for 2h at room 
temperature. Then the membranes were washed 3 times for 10min in TBST 
and incubated with the corresponding secondary antibodies, diluted in TBST, 
for 1h at room temperature. This was followed by a g a in  washing 3 times 
f o r  10min in TBST. The antibodies bound to the membranes were detected 
by Uptilight HRP blot Reagent A (Uptima) or SuperSignal West Dura 
Extendent Duration Substrate (Pierce). 
 
4.5. Biochemical characterization of two putative DNA ligases in the 
radioresistant bacterium Deinococcus radiodurans 
My contribution in this study was the characterization of the divalent cation 
requirements, as well as the ligation activities. Furthermore, I helped in 
preparing the manuscript, specially in making the scheme of the ligase 
domains, represented in Figure 1B. For details see 5.1.1: Original research 
article “Enzymes involved in the DNA ligation and end-healing in the 
radioresistant bacterium Deinococcus radiodurans” (Blasius et al., BMC 
Molecular Biology (2007) 8, 69). 
 
4.6. O6-methylguanine-DNA methyltransferase (MGMT) of Deinococcus 
radiodurans 
4.6.1. Cloning of MGMT 
Cloning was done using D. radiodurans genomic DNA as a template and 
400nM of each forward and reverse primer (Forward: 5’-
CTAGCGGATCCGTTGAGGGCCAGGCCG-3’; Reverse: 5’-
CGCCCGGAATTCCTACAGAAGACGTTGAGC-3’; restriction sites are 
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depicted in italic), as well as 50% DMSO, 200µM dNTPs, 1x HF-buffer and 2 
units of PhusionTM High-Fidelity DNA pol (both from Finnzymes). PCR was 
done in a final reaction volume of 50µl; the cycle program was as follows: 
95°C for 1min, 95°C for 30sec, 55°C for 30sec and 73°C for 1min. The final 
elongation was again at 73°C for 5min. The three middle segments were 
repeated 35 times. After digestion of the PCR-fragment with BamHI and 
EcoRI (New England Biolabs) for 1h at 37°C, it was ligated into a pRSETb 
vector (Invitrogen) overnight at 16°C by the T4 DNA Ligase (Fermentas). 
Then, E. coli DH5& cells (Invitrogen) were transformed with the ligation-mix 
and plated on LB-agarplates, containing ampicillin to select for transformed 
bacteria. Colonies were picked the next day and an overnight liquid LB 
culture was inoculated, whereof the following day, the plasmid was purified 
according to the manufacturers protocol (NucleoBond plasmid purification, 
high copy plasmid purification by Macherey-Nagel). The plasmid was 
subsequently sent for sequencing (Microsynth). 
 
4.6.2. Purification of MGMT 
2 liters of BL21(DE3) E. coli cells (Novagen), carrying the pRSETb-vector with 
the integrated MGMT-sequence, were grown to an OD600 of 0.5 – 0.7 and 
expression of the MGMT protein was induced by adding IPTG to a final 
concentration of 1mM. Cells were kept at 20°C for 2h before centrifuging for 
30min at 4000 rpm in a pre-cooled Sorvall H6000A rotor. All further 
purification steps were done at 4°C. The cells were resuspended in 20ml 
buffer A (10mM Tris/HCl pH 7.5, 30mM KH2PO4, 500mM NaCl, 10mM 
Imidazole and 1mM PMSF), containing lysoszyme (1mg/ml). Cells were kept 
for lysis for 2h at 4°C. After this, the cells were sonicated (on ice, 10sec, 40% 
duty cells, Branson Sonifier Cell disruptor B15) and centrifuged for 30min at 
20000rpm in a pre-cooled sorvall SS-34 rotor. The supernatant was then 
loaded onto a 1ml HisTrapTMHP column using an ÄKTApurifier™ (both GE 
Healthcare). After washing with 5 column volumes, the buffer was exchanged 
to buffer B (10mM Tris/HCl pH 7.5, 30mM KH2PO4, 50mM NaCl, 10mM 
imidazole and 1mM PMSF). After an equilibration step, the protein was eluted 
from the His-column with buffer C (10mM Tris/HCl pH 7.5, 30mM KH2PO4, 
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50mM NaCl, 1M imidazole and 1mM PMSF). The eluted fractions were 
pooled according to a Coomassie Blue R250 stained SDS-PAGE, loaded 
onto a HiTrapTMQ HP column (from GE Healthcare), which was equilibrated 
in buffer D (50mM Tris/HCl pH7.5, 50mM NaCl, 0.1mM EDTA and 10% (v/v) 
glycerol). Under these conditions MGMT does not bind. Protein 
concentrations were determined by Bradford, and the purity of MGMT was 
estimated on an SDS-PAGE gel stained with Coomassie Blue R250. 
 
4.6.3. Band shift assay 
(i) An in DH5& E. coli cells amplified and subsequently purified (NucleoBond 
plasmid purification, high copy plasmid purification by Macherey-Nagel) 
pRSETb plasmid vector was digested with BamHI and EcoRI to linearize the 
DNA. Next, 90ng of plasmid DNA was incubated with the putative MGMT in a 
mix supplemented with 50mM Tris/HCl, pH 7.5. After 15min incubation at 
37°C, 50% sucrose was added and the mix loaded onto a 0.75% agarose gel 
without ethidium bromide. Separation was achieved by running it for 5h with 
35-40V. Then, the gel was stained with ethidium bromide for 1h, followed by 3 
times 5min destaining. 
(ii) An alternative band shift assay was provided by F. Fischer and J. Jiricny 
from the IMCR: The reaction was done in a final volume of 20µl, containing 
10% (v/v) gylcerole, 100mM KCl, 25mM Hepes/KOH pH 7.0, 1mM DTT, 
0.5mM MgCl2, 0.1mM ADP, 0.1mg/ml BSA, 60ng polydC, 50fmol template-
DNA, and either 0.2U hMGMT from Sigma, or the indicated amounts of the 
putative MGMT from D. radiodurans. The reaction was incubated for 10min at 
37°C. Then proteinase K was added to a final concentration of 0.06mg/ml. 
The reaction was incubated for 15min at 37°C, followed by a heat-inactivation 
for 15min at 70°C. Then, MutS& was added to a final concentration of 
0.0275mg/ml. The reaction was again incubated for 15min at 37°C. Then, 
10µl were loaded onto a 5% polyacrylamide gel and the bands were 
separated. 
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4.6.4. MGMT DNA-substrate preparation for a trichloroacetic acid assay 
500µl calf thymus DNA (2mg/ml) were mixed with 20µl of [3H]MNU (0.2mCi) 
and put at 37°C for 4h. Then, the DNA was precipitated by adding 0.1 volume 
of 3M sodium acetate (CH3COONa) and 2 volumes of cold ethanol and 
subsequently put at –20°C for at least 1h. The mix was then centrifuged for 
30min at 14000rpm at 4°C. The pellet was washed three times with cold 95% 
(v/v) ethanol; in between it was again centrifuged for 20min. Finally, the pellet 
was dried and re-dissolved overnight at 4°C in 0.15M sodium chloride (NaCl) 
containing 0.015M sodium citrate (Na3C6H5O7) (in a total volume of 0.5ml). 
The next day, the DNA was precipitated and dried as described above. Finall, 
it was re-dissolved in 0.5ml of 50mM Tris/HCl, pH 8.0 and stored at -20°C 
until use. 
 
4.6.5. O6-methylguanine-DNA methyltransferase assay 
The reaction mix contained 70mM Hepes/KOH pH 7.8, 1mM DTT, 5mM 
EDTA, 10µg BSA, 78000 dpm DNA and the indicated amounts of MGMT in a 
final volume of 100µl. Human MGMT from Alexis was used as a positive 
control. The mix was put at 37°C for 15min, followed by the addition of 500µl 
5% (v/v) Trichloroacetic acid (TCA) to terminate the reaction. Then, the 
reaction was put at 90°C for 15min to hydrolyze the DNA in TCA, followed by 
cooling down on ice for additional 15min. Then 100µl BSA (1mg/ml) were 
added and the mix was transferred onto filter under suction (Whatman GF/C 
filter, 2.5cm in diameter). The filters were washed three times with TCA, 
followed by one wash with ethanol. Finally, the radioactivity was measured in 
a liquid scintillation counter. 
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4.7. Interaction studies of the human apurinic/apyrimidinic 
endonuclease 1 (Ape1) and its fragments with the Rad9/Rad1/Hus1 (9-1-
1) complex 
4.7.1. Cloning of wild-type Ape1 and its untagged fragments 
Six different truncated Ape1 fragments were generated; all forward primers 
contained a restriction site for NheI (in italic), all reverse primers one for 
BamHI (in italic, too). 
Forward primer full-lenght fragment: 5`-ATG GCT AGC CCC AAG CGT GGG 
AAA AAG GGA GC-3`; 
Reverse primer full-length fragment: 5’-TAG GGA TCC TCA CAG TGC TAG 
GTA TAG GG-3’; 
Reverse primer fragment A: 5`-TTA GGA TCC CTC TGA ACA TTT GGT CTC 
TTG AAG GC-3’; 
Forward primer fragment B: 5`-CAT GCT AGC GAG AAC AAA CTA CCA 
GCT GAA CTT CAG G-3’; 
Reverse primer fragment B 5`-ATA GGA TCC GTT CCC CTT GG GTT GCG 
AAG G-3’; 
Forward primer fragment C: 5`-TCA GCT AGC GGG AAC AAA AAG AAT 
GCT GGC-3`. 
PCR was done in a total volume of 50µl, containing 5ng DNA, 1x HF-buffer, 
200µl of each dNTP, 400nM of each forward and reverse primer and 2U 
PhusionTM High-Fidelity DNA pol. PCR cycles were 30sec at 98°C, 10sec at 
98°C, 20sec at 68°C, 20sec at 72°C and final elongation for 5min at 72°C. 
The middle part was repeated 35 times. PCR products were digested with 
NheI and BamHI and ligated into a pET11a vector using T4 DNA ligase. The 
sequences were verified by Microsynth. 
 
4.7.2. Purification of wild-type Ape1 and its untagged fragments 
Cultures of E. coli BL21(DE3) or E. coli BH110 (knock-out strain for xth and 
nfo; kindly provided by M. Saparbaev) cells transformed with the respective 
expression plasmid were grown in LB medium supplemented with the 
required antibiotics at 37°C to an OD600 of 0.4–0.8, then IPTG was added to a 
35
35
35353735
 36 
final concentration of 1mM and cells were further incubated for 2–4h at 37°C. 
Cells were washed with 20ml of washing buffer (20mM Tris/HCl pH 7.5 and 
100mM NaCl), resuspended in Buffer A (20mM Hepes/KOH pH 7.5) and lysed 
with a French press. Cell lysate was centrifuged in a Sorvall SS-34 rotor and 
the supernatant was diluted to 1/6 final volume of Buffer B (20mM 
Hepes/KOH pH 7.5, 1M NaCl) and loaded onto a 1ml HiTrapTMQ Sepharose 
column which was equilibrated with 20% Buffer B. The flow-through was 
directly loaded onto a 1ml HiTrapTMHeparin column equilibrated with 10% 
Buffer B. Gradient elution was performed with 10% to 70% Buffer B. The 
eluted protein was pooled according to a SDS-PAGE gel stained with 
Coomassie Blue. 
 
4.7.3. Cloning of HA-tagged full-length Ape1 and its fragments 
Six different truncated Ape1 fragments were generated; all forward primers 
contained a restriction site for NheI (in italic), all reverse primers one for 
BamHI (in italic, too). In addition, the reverse primers harbor the sequence for 
the HA tag (hemagglutinin epitope of human influenza A virus; underlined). 
Forward primer full-lenght fragment: 5`-ATG GCT AGC CCC AAG CGT GGG 
AAA AAG GGA GC-3`; 
Reverse primer full-length fragment: 5`-TAG GGA TC CTC ATG CGT AGT 
CAG GCA CGT CGT AAG GAT AAG CCA GTG CTA GGT ATA GGG-3’. 
Reverse primer fragment A: 5`-ATA GGA TCC TGC GTA GTC AGG CAC 
GTC GTA AGG ATA AGC GTT CCC CTT GGG GTT GCG AAG G-3’. 
Forward primer fragment B: 5`-CAT GCT AGC GAG AAC AAA CTA CCA 
GCT GAA CTT CAG G-3’. 
Reverse primer fragment B: 5`-ATT GGA TCC TCA TGC GTA GTC AGG 
CAC GTC GTA AGG ATA AGC CTC TGA ACA TTT GGT CTC TTG AAG 
GC-3`. 
Forward primer fragment C: 5`-TCA GCT AGC GGG AAC AAA AAG AAT 
GCT GGC-3`. 
PCR was done as described in 4.7.3. PCR products were digested with NheI 
and BamHI and ligated into a pET11a vector using T4 DNA ligase. The 
sequences were verified by Microsynth. 
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4.7.4. Purification of the HA-tagged full-length Ape1 and its fragments 
Purification of the Ape1 fragments A, AB, B, BC and C, as well as the tagged 
full-length Ape1 was performed by using an adapted protocol as was used for 
the Ape1 untagged wild-type protein. Since the fragments carry a negative net 
charge due to changed isoelectric point (pI) values ranging from 5.2 to 6.6, 
the proteins bind to an anion exchange column such as Q sepharose but not 
to a cation exchange column with the previously described buffer conditions. 
The fragments were eluted from Q sepharose and further purified according to 
the original protocol. Since the purification was not efficient, the pH conditions 
were then adjusted to pH 5.5 with a Hepes/KOH-based buffer in order to 
achieve a positive net charge of the fragments, but also with this adjustment, 
purification was not efficient to achieve reasonable amounts of pure protein. 
 
4.7.5. Preparation of radiolabeled primer/templates for the endonulcease 
assay with Ape1 fragments on anti-HA beads 
To prepare the 100mer oligonucleotide (for sequence see [92]) for the AP 
endonuclease assay, the 100mer was labeled at its 5` end by T4 
polynucleotide kinase (2U) in a final reaction volume of 20!l, containing 1x 
PNK buffer, 4!M 100mer oligonucleotide with an abasic site (AP site) at 
position 43 and 20!Ci [! -32P] dATP (Primers were from Mycrosynth, !ATP 
was purchased from Amersham Biosciences, T4 polynucleotide kinase as 
well as its buffer was from New England Biolabs). The mix was then 
incubated for 40min at 37°C, the kinase inactivated for 10min at 80°C and 
the mix centrifuged through a G-25 (MicrospinTM) column at 720x g for 2min 
to remove the free ATP. The reaction was added to the annealing mix 
containing following reagents in a final volume of 36!l: 4!M 100mer 
oligonucleotide without AP site and 1x annealing buffer. This mix was heated 
at 95°C for 10min and slowly cooled down to room temperature overnight to 
allow the primer to anneal to the template. 
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4.7.6. Endonuclease assay with HA-tagged Ape1 fragments on anti-HA 
beads 
The reactions were carried out in a reaction mixture (10µl) containing 45mM 
Hepes/KOH pH 7.8, 70mM KCl, 7.5mM MgCl2, 2mM DDT, 0.5mM EDTA, 
0.1mg/ml BSA, 2mM ATP, 50fmol of oligonucleotide substrate and the 
indicated amounts of Ape1 and its fragments, respectively, as determined by 
western blot analysis. Reactions were incubated at 37°C for 20min and 
stopped by adding an equal volume of gel loading buffer. Following incubation 
at 100°C for 5min, the reaction products were separated by electrophoresis 
on a 10% denaturing polyacrylamide gel and visualized by autoradiography. 
 
4.7.7. Pull-down assay of HA-tagged Ape1 fragmenst with the 9-1-1 
complex 
For the HA pull-downs, 120µl of HA-slurry were equilibrated with pull-down 
buffer (40mM Tris/HCl pH 8.0, 150mM NaCl, 5mM MgCl2, 10% (v/v) glycerol, 
0.05% (v/v) NP-40) and then added to the E. coli cell lysates, containing the 
overexpressed Ape1 fragments, followed by incubation for 2h at 4°C. As a 
negative control, E. coli cell lysate containing the empty vector was incubated 
with the beads. After three times washing for 10min, 5µg of purified 9-1-1 
complex was added and incubated for another 2h at 4°C in pull-down buffer. 
Next, the mix was centrifuged (4000rpm for 1min at 4°C) and the supernatant 
was removed. Beads were again washed three times in pull-down buffer and 
then heated to 95°C in Laemmli buffer. The co-precipitated proteins were 
analyzed by western blot using the corresponding antibodies according to 
established methods. 
 
4.7.8. Far western 
4µg of DNA pol " was loaded onto a SDS-PAGE gel as a positive control, 
along with 2.5 and 5µg of DNA pol ! and 5 and 10µg BSA as negative 
controls. After separation, the proteins were transferred onto a nitrocellulose 
membrane as described under point 4.4 in this thesis. Then, the proteins were 
renatured on the membrane, using decreasing amounts of guanidine-HCl, 
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starting with 6M and always dividing the amount by two in the next step. 
Seven steps were carried out, each for 10min at 4°C, until reaching a 
concentration of guanidine-HCl of 93.75mM. The membrane was then 
blocked with TBST (0.3% (v/v) Tween20), containing 10% (w/v) milk powder 
for 30min at 4°C. Then, the membrane was incubated with the purified bait 
protein (9-1-1 complex, 5µg in 5ml in protein-binding buffer) and kept at 4°C 
for 1h. After this, four washing steps, each for 10min and with TBST 
supplemented with 0.25% (w/v) milk powder were done, whereby in the 
second wash additionally 0.0001% glutaraldehyd is added. Then, the blot was 
further processed according to the protocol for western blotting, using as a 
first antibody one that is directed against the bait protein. 
 
4.8. Interaction studies of human DNA polymerase !  with the 9-1-1 
complex 
4.8.1 Co-immunoprecicpitation (co-IP) experiments 
(i) For co-IPs, 60mg Protein A sepharose beads were coated overnight with 
1mg BSA in 1ml IP buffer (50mM Tri/HCl pH8.0, 100mM NaCl, 0.05% (v/v) 
NP40, 2µg/ml leupeptin, 1µg/ml bestatin, 1µg/ml pepstatin) at 4°C.The next 
day the beads were washed 3 times with 1ml of IP buffer and resuspended in 
0.5ml IP buffer. Subsequently, the beads (40µl per assay point) were 
incubated for 2h at 4°C with 2.5µl of polyclonal anti-Rad9 antibody in IP 
buffer. For the negative control antibody was omitted. Beads were then 
washed three times with IP buffer (0.5ml, 10min at 4°C, then centrifugation 
with 3000rpm for 1min at 4°C). Meanwhile, 6µg of DNA pol ! was incubated 
with 3.6µg of the 9-1-1 complex, or with the same volume of dilution buffer, 
and the mix was incubated at 4°C for 2h. Subsequently, 40µl of beads were 
added to the pre-incubated proteins and the mix again incubated at 4°C for 
1h. Beads were then washed again three times and finally Laemmli buffer was 
added and samples were analyzed on western blot. 
(ii) 1mg of total HeLa cell extract was immunoprecipitated with the indicated 
antibodies and protein G-sepharose or protein A-sepharose for 1 hour at 4°C. 
After incubation, the supernatant was removed and the beads were washed 
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three times in IP buffer and subsequently heated to 95°C in Laemmli buffer. 
The co-immunoprecipitated proteins were then analyzed by western blot, 
using the corresponding antibodies according to established methods. 
(iii) The other protocol used was established before [120]. In short, protein A-
sepharose or protein G-sepharose beads were coated with 10mg/ml BSA in 
100µl IP buffer (40mM Tris/HCl pH 7.5, 2.5mM MgCl, 0.5% (v/v) NP40, 
2µg/ml leupeptin, 1µg/ml pepstatin and 1µg/ml bestatin) overnight at 4°C. The 
next day, the beads were washed three times with IP buffer (5min each, at 
4°C, spin for 30sec at 5000rpm in cooling centrifuge). Then, they were 
resuspended in 60µl buffer per sample. The antibodies were incubated with 
1mg/ml of the extract in a total volume of 500µl for 2h at 4°C. Then, 60µl of 
coated beads were added per sample and further incubated for 1h at 4°C. 
The beads were then washed three times in washing buffer (50mM Tris/HCl 
pH 8.0, 0.1% (v/v) NP40, 50mM NaCl, 75mM KCl, 2µg/ml leupeptin, 1µg/ml 
pepstatin and 1µg/ml bestatin) and finally the pellet was eluted in 40µl of 
Laemmli buffer by boiling for 10min at 95°C and the supernatant analyzed by 
western blot. 
 
4.9. Paper submitted “Residue 505 of human DNA polymerase !  acts as 
a molecular gate for O-6-methylguanine lesion bypass” 
4.9.1. Site-directed mutagenesis of DNA polymerase !  
Site-directed mutations were preformed according to the protocol of the 
QuikChangeTM Site-Directed Mutagenesis Kit (Stratagene). The mutations 
were introduced into a human DNA pol ! overexpression plasmid (pRSETb-
hpol!-wt; 5ng per reaction) by a PCR-based method with the following 
oligonucleotides (0.2 µM final concentration in 50µl total volume): 
Y505M_Forward: 5`-GCC TGT GCC CTG CTC ATG TTC ACC GGC TCT 
GCA C-3` 
Y505M_Reverse: 5`-GTG CAG AGC CGG TGA ACA TGA GCA GGG CAC 
AGG C-3` 
R517L_Forward: 5`-CAA CCG CTC CAT GCT AGC CCT GGC CAA AAC 
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CAA GGG-3` 
R517L_Reverse: 5`-CCC TTG GTT TTG GCC AGG GCT AGC ATG GAG 
CGG TTG-3` 
The first segment of the PCR was done for 30sec at 98°C. The second 
segment was started at 98°C for 30sec, followed by 65°C for 60sec 
followed by 1min 40sec at 72°C; the final elongation step was done at 72°C 
for 5min. The PCR products were digested with Dpn1 for 60min at 37°C to 
remove the template. Phusion buffer and the DNA pol used for PCR were 
from Finnzyme. Purification of all the mutant plasmids was performed 
according to the manufactors instructions (NucleoBond plasmid purification, 
high copy plasmid purification by Macherey-Nagel). 
The double mutant was done based on the Y505M mutant, using the primers 
used before for the single mutant R517L. All plasmids were sent to 
Microsynth for sequencing before further experiments were performed. 
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5. Results 
5.1. Study of DNA repair enzymes in the radioresistant bacterium 
Deinococcus radiodurans 
5.1.1. Original research article; “Enzymes involved in DNA ligation and 
end-healing in the radioresistant bacterium Deinococcus radiodurans” 
BMC Molecular Biology (2007) 8;69. 
I contributed to the designed schematic outline of the predicted domain 
structures of the Deinococcus radiodurans (D. radiodurans) putative NAD+-
dependent DNA ligase and ATP-dependent DNA ligase represented in Figure 
1B. Furthermore, I was involved in the biochemical characterization of the 
NAD+-dependent DNA ligase, mainly in the analysis of the metal ions 
requirements represented in Figure 3A. 
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5.1.2. The putative O6-methylguanine-DNA methyltransferase (MGMT) of 
Deinococcus radiodurans 
5.1.2.1. Cloning, expression and purification of MGMT 
The putative O6-methylguanine-DNA methyltransferase (MGMT) of D. 
radiodurans was identified by Makarova et al. by using sequence homology 
comparisons [20, 121]. In order to analyze its potential role in DNA damage 
repair, the putative MGMT of D. radiodurans was cloned from genomic DNA. 
Several conditions were tested to achieve optimal protein expression. A 
soluble protein corresponding to the predicted size of 15.3 kDa was 
expressed sufficiently when bacteria where grown at 20°C for 2 hours after 
induction. Based on this result from the small-scale pre-experiments, one liter 
of Escherichia coli (E. coli) culture was used for large-scale expression. For 
purification of the expressed MGMT protein, an affinity chromatography was 
performed using a Nickel column that binds the expressed MGMT due to its 
N-terminal His-tag. The eluate from the Nickel column was further purified via 
a MonoQ column, an anion exchange column. The MGMT protein itself does 
not bind to this column. After purification through these two columns the 
MGMT was more than 99% pure as judged on a 15% SDS-PAGE gel (Figure 
8). 
     
Figure 8. SDS-PAGE gel after purification of the putative MGMT of D. 
radiodurans. The D. radiodurans putative MGMT was purified over a Nickel affinity 
column and a MonoQ anion exchange column to near homogeneity as described in 
Materials and Methods and in the text. The protein was loaded onto a 15% SDS-
PAGE and the gel was stained with Coomassie Blue R250. Lane 1: stained low 
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molecular weight (LMW) marker proteins and their respective sizes in kDa. Lane 2: 
purified MGMT protein (2.5µg). 
 
5.1.2.2. Characterization of the putative MGMT 
Bandshift assay. First, a band shift assay was used to test whether the 
putative MGMT of D. radiodurans can bind to DNA. For this purpose, the 
pRSETb vector was linearized and incubated with the purified putative D. 
radiodurans MGMT for 15min at 37°C. Then, the reaction mix was loaded on 
a 0.75% agarose gel that was stained with ethidium bromide after running. As 
shown in Figure 9, the main band was gradually disappearing with increasing 
amounts of the purified protein and two new bands were appearing 
accordingly (see asterisks in lane 7). One of these bands was running slower 
than the initial band, the other was running faster. This result suggested that 
the putative MGMT bound to DNA, resulting in a band that runs slower than 
the initial linearized DNA. The second band could be due to cutting of the 
vector DNA at a specific site by the putative MGMT, leading to a smaller 
fragment that is running faster than the longer, original linearized plasmid. 
However the purified MGMT might still be contaminated with an endonuclease 
that was co-purified in trace amounts.  
 
   
Figure 9. Bandshift assay using a linearized vector as a DNA template. The 
bandshift assay was performed as described in Materials and Methods. Lane 1: 
negative control (MGMT dilution buffer only). Lanes 2 to 7: increasing amounts of D. 
radiodurans MGMT protein were tested. Lane 8: !-PST marker. Asterisks indicate 
the newly appearing bands, running slower and faster as the original one, 
respectively. 
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Indirect bandshift assay. To further investigate the DNA binding capacity of the 
putative MGMT of D. radiodurans, a collaboration with Franziska Fischer from 
Prof. Dr. J. Jiricny’s laboratory at the Institute for Molecular Cancer Research 
(IMCR, Zürich) was initiated. MutS& binds to G/T mismatches if the respective 
guanine base is unmodified. In the approach used here, such an unmodified 
guanine base is achieved by demethylation by MGMT. For the assay, a linear 
oligonucleotide with a methylated guanine paired to a thymine is incubated 
with the MGMT proteins (hMGMT from Sigma as a positive control and the 
putative D. radiodurans MGMT under investigation). An active MGMT can 
transfer the methyl group form the guanine residue to its internal cysteine 
acceptor site, hence creating an unmodified guanine base. After incubation, 
proteinase K is added to the reaction mix to ensure removal of all MGMT 
proteins from the template. After heat inactivation of proteinase K, MutS& is 
added and can bind to the available G/T mismatches. The resulting DNA-
protein complex can be detected by separation on an gel, as the respective 
DNA band is shifted in comparison to a template-only fragment. The positive 
control using an unmodified template showed a bandshift upon incubation 
with MutS&, in agreement with binding of MutS& to the template, resulting in a 
DNA-protein complex migrating slower than the template-only (Figure 10, lane 
1). Upon incubation of the methylated template with MutS& no shift was 
detected, as MutS& cannot bind to a methylated guanine base (lane 2). 
Incubation of the methylated template with hMGMT prior to the addition of 
MutS& resulted in a shifted band, indicating removal of the methyl group from 
the DNA (lane 3). Upon incubation of the methylated template with the 
putative MGMT of D. radiodurans, a bandshift was observed. However, this 
shifted band was running at an intermediate position compared to the 
template-only band and the observed shifted band for the template bound by 
MutS& (see lanes 7-9, asterisks). This might be due to the fact that the D. 
radiodurans MGMT bound to the DNA but was afterwards not digested by 
proteinase K, thus remaining on the DNA. This could then impede the binding 
of MutS&, hence, the observed shift would rather be a result of MGMT binding 
to the DNA than MutS&. Although the reaction conditions were varied (without 
57
57
57575957
 58 
KCl or substituting KCl by NaCl), no bandshift indicating MutS& binding to the 
template was observed. 
   
Figure 10. Bandshift assay using a template with a G/T-mismatch. The bandshift 
assay was performed as described in Materials and Methods. Two templates were 
used; in one, the guanine was not modified, in the other it was methylated. Lanes 1 
and 2: unmodified and modified template, respectively, incubated with MutS& only. 
Lane 3: methylated template, preincubated with the human MGMT before the 
addition of MutS&. Lanes 4 to 9: titration of the D. radiodurans MGMT using the 
indicated amounts. Lane 10: control template with a A/T match. Asterisks indicate 
intermediate shifts. 
 
O6-methylguanine-DNA methyltransferase activity of MGMT 
Trichloroacetic acid (TCA)-Assay. The purified putative MGMT from D. 
radiodurans was next tested for its ability to transfer a radiolabeled methyl 
group from a previously prepared calf-thymus DNA substrate onto its 
internally located cystein acceptor residue. In a trichloroacetic acid (TCA) 
assay titrating the putative D. radiodrurans MGMT, the highest activity was 
observed with an amount of 500pmol (Figure 11A). With higher amounts, a 
higher activity was not evident, in contrary, the relative activity decreased 
significantly. However, the expression efficiency of the protein was very 
variable and therefore not always batches of purified proteins that would have 
58
58
58586058
 59 
allowed the use of 500pmol could be achieved. Each experiment was 
performed in triplicate and all experiments were repeated at least three times. 
However, significant variations were observed between triplicates as well as 
between experiments, which is reflected in the high standard deviations (see 
for example Figure 11A). Furthermore, the actually measured counts per 
minute (cpm) numbers were close to the limit of detection. Accordingly, the 
observed relative activity of the positive control, namely purchased purified 
human MGMT (hMGMT; from Alexis), was not significantly above background 
levels (see Figure 11E). Nevertheless, different reaction conditions were 
tested in order to optimize the TCA assay. However, neither different amounts 
of EDTA (Fig. 11B), titration of different cations such as Na+ or Mn2+ (Figure 
11C and D) or variation of pH (Figure 11E) in the reaction conditions, nor the 
application of D. radiodurans whole cell extracts (Figure 11F) in the TCA 
assay resulted in conclusive results. 
In summary, it was impossible to detect any MGMT activity in the putative 
MGMT protein. The previous data suggested that the protein was correctly 
folded since it could bind to DNA. However, an explanation for the unapparent 
methyltransferase activity could lie in the reaction mechanism of MGMTs; in 
contrast to classical enzymes, an individual MGMT protein cannot catalyze in 
a classical way; it only enables one single transferase action. Thus, it was 
generally difficult to detect MGMT protein activity with this assay, which was 
confirmed by the low activity of the hMGMT (see also Discussion). 
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Figure 11. Activity measurements of D. radiodurans putative MGMT. The assay 
was performed as described in Materials and Methods. D. radiodurans putative 
MGMT amount was kept constant (100pmol in all the experiments except for 11A 
and F). A) Titration of the D. radiodurans putative MGMT. Note the high standard 
deviations as well as the negative results with high amounts of the purified protein. 
B) Titration of EDTA. C) Titration of MnCl2. D) Titration of NaCl. E) Test of different 
pH conditions. F) Titration of D. radiodurans cell extracts. As a positive control, the 
human MGMT was used in all the experiments; as a negative control MGMT dilution 
buffer only was added. All experiments were done at least in triplicates and standard 
deviations are given. Y-axis: cmp = counts per minute. 
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However, the results obtained, even though disappointing at the time made, 
became clearer in the view of a very recent publication, suggesting that 
MGMTs and alkyltransferase-like (ATL) proteins from prokaryotes as well as 
from lower eukaryotes are inactive in vitro, since they simply flip the alkylated 
base out of the DNA helix, leaving the lesion to be repaired by proteins of the 
nucleotide exision repair pathway. Those data support the negative findings 
with the D. radiodurans MGMT protein ([122] and Discussion). 
5.2. Studies of human DNA repair enzymes 
5.2.1. Interaction of the human apurinic/apyrimidinic endonuclease 1 
(Ape1) with the Rad9/Rad1/Hus1 (9-1-1) complex 
5.2.1.1. Previous results 
Components of the base excision repair (BER) pathway were previously 
shown to interact with the 9-1-1 complex. The latest findings came from 
Gembka et al. [92], showing that the 9-1-1 complex not only interacts with 
Ape1 but also stimulates its endonuclease activity in an in vitro reconstituted 
BER system. Tabelle 1 documents a summary of the so far known BER-
participating interaction partners of the 9-1-1 complex. 
 
LP-BER component Functional 
consequence 
Reference 
MutY DNA glycosylase Stimulation of 
glycosylase activity 
[90, 94] 
Ape1 Stimulation of AP 
endonuclease activity 
[92] 
DNA pol ! Stimulation of 
polymerase and strand 
displacement activities 
[96] 
Fen 1 Stimulation of endo- and 
exonuclease activities 
[91, 97] 
Lig I Stimulation of ligase 
activity 
[95, 98] 
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To further study the interaction of the 9-1-1 complex with Ape1, Ape1 
fragments were generated to narrow down the interaction site and get more 
insights about its functional relevance. 
 
5.2.1.2. Cloning, expression and purification of human Ape1 fragments 
Ape1 was subdivided into three distinct regions according to their predicted 
functions [65], namely an N-terminal part, a middle part and a C-terminal part 
(see Figure 12). The N-terminal part (further referred to as part A) encloses 
the nuclear localization signal (NLS) and residues, which are required for the 
redox and endonucleatic functions. The middle part (further referred to as part 
B) harbors three predicted binding motifs suggested to be involved in the 
interaction with the 9-1-1 complex [123]. The C-terminal part (further referred 
to as part C) contains putative phosphorylation sites as well as residues that 
are supposedly essential for the protein`s conformation and catalysis . 
 
  
Figure 12. Nucleotide sequence of the human Ape1 gene according to the 
PubMed database. The nuclear localization signal is depicted in brown and the 
acetylation sites in yellow. Nucleotides encoding residues required for redox activity 
and endonuclease activity are in light green and dark green, respectively. 
Nucleotides encoding potential phosphorylation sites are shown in red, nucleotides 
encoding residues that are important for conformation and catalysis are in pink. 
Highlighted with yellow boxes are the putative 9-1-1 interaction motifs 1 & 2, and 3, 
respectively. Arrows indicate beginning and ends of the fragments. 
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In a first step, the three fragments and combinations thereof were cloned 
without an additional tag for detection. However, the subsequent purification 
failed due to detection problems. The anti-Ape1 antibody used was sufficiently 
specific to detect the purified wild-type Ape1, but a clear distinction of the 
expressed Ape1 fragments from unspecific bands in E. coli lysates was not 
possible. The expression of the fragments could not be boosted to sufficiently 
high levels either, which would have allowed clear discrimination from 
unspecific bands without an antibody. In any case no further experiments 
could be performed with the untagged Ape1 fragments. As the Rad9 subunit 
of the 9-1-1 complex was already carrying a hexa-histidine tag (his-tag) and a 
GST-tag would have been rather large compared to the small Ape1 
fragments, an HA-tag was introduced at the C-terminus of each fragment. The 
HA-tag consists of nine amino acids and thus interferes usually not with the 
folding of the tagged protein. After successful cloning and verification of the 
sequence by Microsynth, the truncated proteins were expressed in BH110 E. 
coli cells (kindly provided by M. Saparbaev), which are double mutants for the 
E. coli Ape1 homologs xth and nfo. The expression conditions were optimized 
for each fragment in a small-scale experiment; overnight expression at 16°C 
turned out to be optimal for fragments A and AB, expression overnight at 
20°C was best for fragment B and BC, and tagged full-length Ape1 and 
fragment C were expressed best after 4 hours at 37°C. Figure 13A shows a 
schematic representation of the different truncated protein fragments. In 
Figure 13B a representative western blot is shown for the expression 
efficiency of the different fragments after optimizing the conditions. Despite 
various attempts at achieving higher expression levels of the truncated 
proteins, the observed expression remained low. In combination with the 
frequently observed impaired cell growth and cell death, respectively, after 
induction of protein expression, this indicated a toxic effect of the protein 
fragments on the E. coli cells. 
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Figure 13. Schematic representation of the Ape1 fragments and their 
expression. A) Schematic representation of the fragments. Full-length; A; AB, which 
consists of A and B; B; BC, which consists of the middle and the C-terminal parts, 
and C. All fragments are C-terminally HA-tagged (dark blue). Dark orange is the 
NLS, light green represents the residues necessary for the redox activity, in dark 
green are the amino acids important for the endonuclease activity. Light orange and 
yellow represent the putative interaction sites with the 9-1-1 complex. B) Western 
blot analysis of expressed fragments with their predicted size, detected on a 15% 
SDS-Page gel incubated with anti-HA antibody; 20µl of total cell lysate was loaded 
per fragment. 
 
For protein purification, an one liter culture of E. coli BH110 bacteria was 
grown and expression of the tagged full-length Ape1 and of each of the five 
fragments was induced by adding 1mM IPTG after reaching an OD600 of 0.5-
0.6. Purification from the E. coli cell extracts was performed by using three 
chromatography columns, being a HiTrapTM Q-sepharose anion exchange 
column, a HiTrapTMHeparin HP affinity/cation exchanger column and an 
HiTrapTMSP HP cation exchange column. In contrast to the purification of 
wild-type Ape1, only little binding of the truncated proteins to the columns was 
observed. This might be due to differences in the isoelectrical point (pI) of the 
wild-type protein and the five fragments. Whereas the untagged wild-type 
Ape1 has a pI of 8.7, the respective protein fragments have pIs ranging from 
6.6 to 5.2, thus resulting in a difference in their net charges. Therefore, next 
the pH of the purification buffers was adjusted to pH 5.5 to achieve a net 
charge of the fragments similar to that of the wild-type Ape1. Despite this pH 
change, the truncated proteins could not be purified in sufficient amounts for 
further experiments. 
A B 
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Finally, anti-HA agarose beads were used to improve the purification 
efficiency of the five fragments. In this case, the protein fragments bound 
efficiently to the matrix but no significant elution was achieved with the 
recommended low pH buffer. Therefore, all further experiments were 
conducted with protein fragments bound to anti-HA beads. 
 
5.2.1.3. Characterization of the Ape1 fragments and their interaction with 
the 9-1-1 complex 
Endonuclease experiments. First, the endonuclease activity of the fragments 
was tested and compared to the untagged full-length Ape1. For this the 
fragments were first coupled to the anti-HA beads followed by washing as 
described in Materials and Methods. Then the beads were incubated with a 
radioactively labeled 100mer oligonucleotide containing an AP site at position 
43. As depicted in Figure 14, 100% cutting at the AP site was detected for 
both, the purified untagged Ape1 and the full-length HA-tagged Ape1 bound to 
anti-HA beads. In case of the fragment A about 50% residual endonuclease 
activity was observed, whereas all other fragments showed no cutting. This 
was expected, since an N-terminally located endonuclease domain was 
predicted [65]. However, quantification of the observed results was not 
possible due to variations in AP endonuclease product formation as well as 
differences in the coupling efficiency of the different protein fragments to the 
anti-HA beads. Therefore, further investigations with a different approach will 
have to be performed to verify the observed results. 
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Figure 14. Endonuclease activity of Ape1 and its fragments on beads. The 
assay was performed as described in Materials and Methods. A) Template used in 
the assay: 100mer containing an abasic site at position 43. B) Endonuclease assay 
with Ape1 protein fragments coupled to HA-beads. Right is the schematic 
representation of the formed DNA after cutting by Ape1 and its fragments. C) 
Western blot representing the coupling efficiency of the different fragments to the 
HA-beads. 
 
Pull-down experiments. To further characterize the interaction between the 9-1-
1 complex and Ape1 [92], pull-down experiments were performed with the five 
Ape1-fragments. In contrast to the experiments described by Gembka et al, 
the fragments carried a HA-tag and were not purified prior to the incubation. 
Instead, the expressed protein fragments from E. coli extracts were bound to 
anti-HA agarose beads, washed and incubated with purified 9-1-1 complex. 
As a positive control, HA-tagged full-length Ape1 was tested. The results are 
shown in Figure 15. 
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Figure 15. Pull down with Ape1 and its five fragments. The HA-tagged protein 
fragments from E. coli cell extracts were bound to HA-beads and incubated with 5µg 
of purified 9-1-1 complex as described in Materials and Methods. Lanes 1 to 6: full-
length Ape1 and the different protein fragments, respectively, as indicated by 
asterisk. Lane 7: cell lysate with the empty vector only. Lane 8: low molecular weight 
marker in kDa. Lane 9: 2% input of the 9-1-1 complex. The blot was incubated with 
anti-Rad9 antibody for detection of the interaction with the 9-1-1 complex and anti-
HA antibody for detection of the bound Ape1 proteins as indicated. The HA-antibody 
also recognizes the antibody light chain, which has a size of roughly 25kDa and is 
indicated with an arrow. 
 
A moderate interaction with the 9-1-1 complex was observed for full-length 
Ape1. In contrast to sequence alignments of Ape1 predicting interaction sites 
in the middle part of the protein (Figure 12 and schematic representation in 
Fig 13), all of the generated fragments appeared to interact with the 9-1-1 
complex (Figure 15). In addition, a band indicating an interaction was 
detected for the negative control, although anti-HA agarose beads were in this 
case incubated with cell extract from BH110 E. coli cells transformed with the 
empty vector. However, it cannot be excluded that the HA-tag might have 
some effect that is interfering with the interaction between the Ape1 and the 9-
1-1 complex. Still it might be possible that the truncated proteins are folded 
differently as compared to the wild-type protein. However, detection of the 
Rad9 subunit in the performed pull-down experiments was considered 
representative for an interaction with the 9-1-1 complex. However, it turned 
out that the anti-Rad9 antibody also recognizes the antibody heavy chains 
present on the anti-HA agarose beads (Figure 16); the resulting western blot 
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band can hardly be separated from the band of the Rad9 subunit. As the 
available anti-Rad1 and anti-Hus1 antibodies cannot be used for these assays 
due to their low sensitivity and the specificity of the anti-His antibody is not 
sufficient, a new antibody would have to be generated for further 
investigations.  
    
Figure 16. The anti-Rad9 antibody recognizes the antibody heavy chain of the 
HA-beads. Lane 1: 2µg purified 9-1-1 complex. Lane 2: Pre-stained low molecular 
weight marker. Lane 3: 20µl slurry HA-beads, after washing with IP-buffer. The 
unspecific band is indicated by an asterisk. The blot was incubated with anti-Rad9 
antibody. 
 
Far western experiments. The interaction the of 9-1-1 complex with the five 
fragments of Ape1 was further tested by far western. In order to establish 
optimal reaction conditions, the previously described interaction of DNA pol " 
with the 9-1-1 complex [96] was verified along with DNA pol ! and BSA as 
negative controls.  
For DNA pol " the expected interaction with the Rad9 subunit was observed. 
However, a band indicating an interaction was also detected for DNA pol ! 
and the 9-1-1 complex (Figure 17, lanes 3 and 4). As expected, no interaction 
was observed with BSA as a negative control. 
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Figure 17. Interaction of DNA pol ! with the 9-1-1 complex. The assay was 
performed as described in Materials and Methods. Lane 1: Interaction of DNA pol " 
and Rad9 of the 9-1-1 complex. Lane 2: Pre-stained low molecular weight marker. 
Lanes 3 and 4: interaction of Rad9 with DNA pol ! in the indicated amounts. Lanes 5 
and 6: BSA as a negative control in two different amounts. The blot was incubated 
with anti-Rad9 antibody. 
 
5.2.4. DNA Polymerase !  interaction with the 9-1-1 complex 
Immunoprecipitation (IP) assay. In order to verify the interaction of DNA pol ! 
with the 9-1-1 complex, immunoprecipitation (IP) experiments were performed 
using purified 9-1-1 complex and DNA pol !. Since the anti-Rad9 antibody 
used binds also to antibody heavy chains in addition to Rad9, and the 
respective signals cannot be clearly separated on SDS-PAGE gels for 
western blots. Therefore, immunoprecipitation of DNA pol ! via an anti-DNA 
pol ! antibody and subsequent detection of co-immunoprecipitated 9-1-1 
complex via the anti-Rad9 antibody was not possible. Thus, a vice versa 
approach was tested with immunoprecipitating the 9-1-1 complex via the anti-
Rad9 antibody and subsequent detection of a DNA pol ! interaction by the 
available DNA pol ! antibody. However, no such interaction was observed 
with this approach. In addition, all in vivo immunoprecipitation experiments 
utilizing HeLa cell extracts showed no obvious interaction of the 9-1-1 
complex and DNA pol !. Further experiments are required to verify these 
initial results indicating a putative interaction of the 9-1-1 complex and DNA 
pol !. 
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5.2.5. Manuscript in preparation 
My contribution to this work was the cloning of the DNA pol ! mutants used in 
this study as described in Materials and Methods. 
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6. Discussion 
6.1. Studies with the model organism Deinococcus radiodurans 
6.1.1. Characterization of two putative DNA ligases of D. radiodurans 
In the first part of this thesis, the identification of a NAD+-dependent DNA 
ligase, together with a second putative ATP-dependent DNA ligase of the 
radioresistant bacterium D. radiodurans is reported. For many years it was 
supposed that bacteria contain only NAD+-dependent DNA ligases. Several 
years ago however, the identification of bacterial ATP-dependent DNA ligases 
was published [124], suggesting that also bacteria might have specific DNA 
ligases for different tasks. Bacterial NAD+-dependent DNA ligases are 
commonly highly conserved, which is also the case for the D. radiodurans 
enzyme. This suggests that the NAD+-dependent DNA ligases are essential 
[19]. 
As described in Blasius et al. [125], the NAD+-dependent DNA ligase of D. 
radiodurans had strong ligation activity on a nicked substrate in the presence 
of NAD+ and MnCl2. This is not surprising, keeping in mind that Mn
2+ ions are 
present in high internal levels in D. radiodurans and are also essential for (-
radiation resistance [126]. Additionally, other enzymes from D. radiodurans 
such as e.g. the family X DNA pol, have been shown to be stimulated by Mn2+ 
[14]. Furthermore, the above mentioned finding of the generally high 
conservation amongst bacterial NAD+-dependent DNA ligases could also be 
confirmed for the D. radiodurans ligase as mutating the conserved lysine 128 
to alanin abolished ligation activity as well as adenylation of the ligase, which 
is the first step in the ligation process. However, the second DNA ligase 
studied and described in Blasius et al. [125] is a putative ATP-dependent DNA 
ligase. In contrast to the before described NAD+-dependent DNA ligase, this 
second ligase is strongly upregulated upon (-irradiation [121], further 
undermining the hypothesis that also bacteria employ different ligases for 
different functions. Also this DNA ligase contains most of the conserved 
amino acid residues present in other ATP-dependent DNA ligases. However, 
as already discussed in Blasius et al. [125], although a specific 
adenylyltransferase intermediate could be shown, no ligase activity was 
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detected. However, the adenylyltransferase activity was intrinsic to the 
putative ATP-dependent DNA ligase, as mutation of the conserved lysine 40 
to alanine abolished the reaction. Certainly, it cannot be ruled out that this 
ligase has particular requirements for specific substrates, although various 
substrates were tested, like nicked DNA, nicked DNA-RNA hybrids, single-
stranded RNA, double-stranded DNA with blunt ends or also with overhangs. 
However, the putative ATP-dependent DNA ligase of D. radiodurans does not 
display any conventional DNA-binding motif what suggests that an additional 
protein might be required as it is the case for mammalian DNA-ligase III, 
which requires the XRCC I protein [18]. Another Deinococcal protein might 
serve this function: PprA was shown to act in a Ku-like manner, tethering free 
DNA ends together. Furthermore, PprA was shown to stimulate ATP- and 
NAD+-dependent DNA ligases [127, 128]. Surely this will need further 
experiments, as also other groups were not successful in clarifying the 
specific requirement that this putative ATP-dependent DNA ligase might have 
or in elucidating potential auxiliary proteins (Mike Cox, personal 
communication). 
6.1.2. Characterization of a putative O6-methylguanine-DNA 
methyltransferase (MGMT) of D. radiodurans 
O6-methylguanine-DNA methyltransferases (MGMT) exist in all three 
kingdoms of life [30]. However, their primary sequence similarity is rather low, 
but the overall domain structure is very similar, comprising a very conserved 
active site cysteine residue, which covalently binds the methyl group of the 
substrate [30]. This covalent linkage is very stable, the enzyme cannot be 
recycled, thus repair of O6-methylguanine lesions occurs in a stoichiometric 
fashion, which quickly leads to saturation if the lesion is too abundantly 
present. In other words, each O6-methylguanine not only acts as a substrate, 
but also as an irreversible inhibitor of the MGMT protein. The MGMT is 
therefore often referred to as “kamikaze” or “suicidal” protein. Thus, it is clear 
that working with MGMT is not trivial, which was confirmed in the studies 
presented here. Although the protein was correctly folded, which was shown 
with different DNA-binding assays, it was not possible to clearly show 
transferase activity, although different cations such as Mn2+ (Figure 11C) and 
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Mg2+ (data not shown) and various buffer conditions were tested. Even when 
testing whole cell extracts of D. radiodurans, it was not possible to detect 
methyltransferase activity although e.g. NAD+-dependent DNA ligase activity 
has been observed in extracts. However, E.coli cells that are not previously 
treated with sublethal doses of alkylating agents before exposing them to 
higher doses of the reagents have been shown to only contain a few dozen 
MGMT molecules; however, after an adaption phase MGMT protein levels 
accumulate to several thousand molecules per cell (reviewed in [129]). Thus, 
it is not surprising that with extract from unadapted cells, no intrinsic MGMT 
activity could be shown due to the low number of MGMT proteins present. 
Furthermore, also a commercially available human MGMT showed only 
minimal transferase activity, which was at the limit of detection. Nevertheless, 
it is very unlikely that the MGMT needs an additional auxiliary protein, as it 
might be the case for the putative ATP-dependent ligase mentioned before. 
MGMTs are known to act without co-factors, which was confirmed in our 
studies, at least for the DNA-binding ability of the Deinococcal MGMT. 
However, another group reported very recently the finding of a new class of 
proteins, named alkyltransferase-like proteins (ATLs) [122]. These ATLs are 
characterized by the lack of the reactive cysteine, to which the methyl group is 
transferred in MGMTs; rather, they have replaced the cysteine residue of the 
active site PCHRV sequence motif by tryptophane, alanine or another 
residue. Indeed, a BLAST search for the putative MGMT of D. radiodurans 
revealed the substitution of the active site cysteine by tryptophane, giving rise 
to a modified sequence motif (PWQRV) and thus suggesting that the 
Deinococcal MGMT belongs to the ATL family of proteins rather than to the 
MGMT family [122]. Due to the absence of the reactive cysteine residue, the 
ATL proteins do not posses any alkyltransferase activity, but are suggested to 
act through the binding of the O6-methylguanine DNA lesion, thereby bending 
the DNA by about 45°, which might mark the DNA for recognition by proteins 
involved in the nucleotide excision repair (NER) pathway finally repairing the 
damage. This is in agreement with the observed DNA-binding capability of the 
putative MGMT of D. radiodurans, as well as with its apparent lack of 
alkyltransferase activity. Thus, the findings with the putative MGMT of D. 
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radiodurans presented in this study fit nicely into the described characteristics 
for an alkyltransferase-like protein. 
 
6.2. Studies with human DNA repair enzymes 
6.2.1. Interaction of the Rad9/Rad1/Hus1 (9-1-1) complex with 
apurinic/apyrimidinic endonuclease 1 (Ape1) and its fragments 
Based on the findings in our Institute (Gembka et al. [92]), the interaction of 
the Rad9/Rad1/Hus1 (9-1-1) complex with the apurinic/apyrimidinic 
endonuclease 1 (Ape1) was examined closer. The Ape1 protein was 
subdivided into five fragments. In a first attempt, the fragments were left 
untagged in order not to interfere with the folding of the proteins, as the 
fragments are quite small, only being about 12 to 26 kDa in size. However, 
the low expression efficiency of the fragments, paired with the inefficient 
recognition by the antibody due to its low sensitivity and specificity, led us to 
re-clone the fragments, including a HA-tag. Although the anti-HA antibody 
detected the light chain of the antibody additionally to the HA-tagged 
fragments, a clear discrimination between the fragments and unspecific 
proteins could be achieved, yet purification was not successful. As already 
observed with the untagged fragments, the expression efficiency remained 
rather low, also with the tagged proteins. Furthermore, an inducible lethality of 
the bacteria expressing the fragments was noticed, which suggests an 
unbeneficial effect of the truncated proteins on the bacteria. This was not due 
to the fact that the bacteria used to express the proteins were knock-outs for 
the bacterial homologs of Ape1, xth and nfo, as also with other bacterial 
strains the same effect was observed (data not shown). However, in addition 
to the inconveniencies with the expression, purification was handicapped by 
the fact that elution from the anti HA-beads, which were used for the 
purification of the tagged proteins, was very inefficient with a pH of 2.5, which 
was recommended by the manufacturer. Even more so, pH as low as this 
might lead to an irreversible inactivation of the protein fragments, thus it 
seemed reasonable to work with the unpurified fragments coupled to the 
beads, without prior elution. This was feasible as endonuclease activity 
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assays indicated that the proteins are active even when they reminded 
coupled to the beads. Moreover, these assays confirmed that the 
endonuclease activity lies in the N-terminal part of the protein, which is in 
agreement with published data [69, 71]. However, when it came to pull-down 
experiments, using the fragments coupled to the anti HA-beads, it emerged 
that this approach was not suitable, as the Rad9 antibody, which was used to 
assess the putative interaction between the 9-1-1 complex and the different 
Ape1 fragments, turned out to recognize the heavy chains of the antibodies, 
present on the anti-HA beads. Although the heavy chain normally runs at a 
size of 55 kDa and the Rad9 protein at 72 kDa, it was not possible to separate 
the two bands conclusively with the 15% SDS-PAGE gels that were used. 
However, neither anti-Rad1 nor anti-Hus1 antibodies could be used to detect 
the interacting 9-1-1 complex due to their low specificity and sensitivity. Still, 
the initially made observation by Gembka et al. [92] could be reproduced 
using purified proteins. For further pull-down purposes it might be convenient 
to work with purified proteins to circumvent inconveniences derivng from 
additional unspecific bands, as it is the case for the antibody light and heavy 
chains. However, additional experiments are required to pin down the exact 
interaction site between the 9-1-1 complex and Ape1. 
6.2.2. Interaction of the Rad9/Rad1/Hus1 (9-1-1) complex with human 
DNA polymerase !  
In the last part of the thesis, observations were made suggesting a novel 
interaction between the 9-1-1 complex and DNA pol !. This finding makes 
sense in the light of various findings made by different groups that place DNA 
pol !, besides its role in non-homologous end joining (NHEJ), also in the 
context of base excision repair (BER). For example, Maga et al. showed that 
DNA pol ! is the DNA pol that most faithfully incorporates a correct dCTP 
opposite a 7,8-dihydro-8-oxoguanine (8-oxo-G) when proliferating nuclear 
antigen (PCNA) and replication protein A (RP-A) are present [119]. In their 
latest findings [118], Maga et al. went a step further, suggesting PCNA and 
RP-A as molecular switches, which activate the highly efficient and faithful 
repair of an A:8-oxo-G mismatch by DNA pol !, simultaneously repressing 
DNA pol " activities. Very recent observations made by Van Loon and 
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Hübscher place DNA pol !, in cooperation with MUTYH, in a novel long patch 
(LP) BER event that prevents C:G to A:T transversion mutations (Manuscript 
submitted). Together with the fact that the 9-1-1 complex interacts and 
stimulates various enzymes involved in BER as sumarazied in Table 1, these 
findings argue for a repair mechanism that proceeds via the coordinated 
stimulation of the different BER enzymes, all tethered together, thus building a 
multienzyme DNA repair complex, as suggested by Balakrishnan et al. [130], 
whereby DNA pol " can be substituted by DNA pol ! to allow faithful repair of 
specific DNA damages. Although the putative interaction between the 9-1-1 
complex and DNA pol ! found here would perfectly fit into the suggested 
model, further experiments have to be performed to sustain those preliminary 
findings. 
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